chapter-420-7-2•Alabama Administrative Code Chapter 420-7-2 — Controlled Substances
Alabama Administrative Code Chapter 420-7-2 — Controlled Substances
chapter-420-7-2Ala. Admin. Code ch. 420-7-2Regulation
420 Alabama Department of Public Health
Ala. Admin. Code r. 420-7-2-.01 Authority
(1) The Alabama Controlled Substances List, shown as Appendix to this Chapter, comprises a complete listing of said substances, pursuant to Code of Ala. 1975, Sections 20-2-1, et seq.
(2) The Controlled Substances List shall be published annually, reflecting the date of adoption and the effective date.
(3) As substances are designated, rescheduled or deleted as controlled substances, the appendix and other publications shall be amended accordingly by adding to said listing a slip-sheet of the action taken and the effective date. Each annual publication, as provided in (2) above, will contain any amendment occurring during that year.
History
- Author: Alabama Department of Public Health
- Authority: Code of Ala. 1975, §§20-2-1, et seq.
- Filed September 1, 1982.
Ala. Admin. Code r. 420-7-2-.02 Definitions
(1) Controlled Substance. A drug, substance or immediate precursor in Schedules I through V of Rule 420-7-2-.03 of this Chapter.
(2) Drug.
(a) Substances recognized as drugs in the official United States pharmacopoeia, official homeopathic pharmacopoeia of the United States or official national formulary or any supplement to any of them;
(b) Substances intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in man or animals;
(c) Substances (other than food) intended to affect the structure or any function of the body of man or animals; and
(d) Substances intended for use as a component of any article specified in paragraphs (a), (b) or (c) of this subdivision. Such term does not include devices or their components, parts or accessories.
(3) Immediate Precursor. A substance which the State Board of Pharmacy has found to be and by rule designates as being the principal compound commonly used or produced primarily for use and which is an immediate chemical intermediary used or likely to be used in the manufacture of a controlled substance, the control of which is necessary to prevent, curtail or limit manufacture.
(4) Marihuana. All parts of the plant Cannabis sativa L., whether growing or not, the seeds thereof, the resin extracted from any part of the plant and every compound, manufacture, salt, derivative, mixture or preparation of the plant, its seeds or resin. Such term does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil or cake or the sterilized seed of the plant which is incapable of germination.
(5) Narcotic Drug. Any of the following, whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis:
(a) Opium and opiate and any salt, compound, derivative or preparation of opium or opiate.
(b) Any salt, compound, isomer, derivative or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (a), but not including the isoquinoline alkaloids of opium.
(c) Opium poppy and poppy straw.
(d) Coca leaves and any salt, compound, derivative or preparation of coca leaves and any salt, compound, isomer, derivative or preparation thereof which is chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions of coca leaves which do not contain cocaine or ecgonine.
(6) Opiate. Any substance having an addiction-forming or addiction-sustaining liability similar to morphine or being capable of conversion into a drug having addiction-forming or addiction sustaining liability. Such term does not include, unless specifically designated as controlled under this section, the dextrorotatory isomer of 3-methoxy-n-methylmorphinan and its salts (dextromethorphan). Such term does include its racemic and levorotatory forms.
(7) Opium Poppy. The plant of the species Papaver somniferum L., except its seeds.
(8) Poppy Straw. All parts, except the seeds, of the opium poppy, after mowing.
History
- Author: Alabama Department of Public Health
- Authority: Code of Ala. 1975, §§20-2-1, et seq.
- Filed September 1, 1982.
Ala. Admin. Code r. 420-7-2-.11 Prescription Drug Monitoring Program - Collection Of Fees To Support The Database
(1) Act No. 2004-443 requires that the following licensing boards shall assess a surcharge in the amount of $10.00 per year on the controlled substance registration certificate issued or renewed each year to a licensee of the respective boards in the State of Alabama. This requirement is to be implemented effective October 12, 2004. A list of the affected licensing boards follows:
(a) Alabama State Board of Medical Examiners
(b) Alabama Board of Optometry
(c) Alabama Board of Dental Examiners
(d) Alabama State Board of Veterinary Medical Examiners
(e) Alabama State Board of Podiatry
(2) By the 10th of each quarter, each affected licensing board shall remit payment of $10.00 for each controlled substance registration certificate issued or renewed. The remittance shall be made payable to the Alabama Department of Public Health, Office of Professional and Support Services.
(3) By October 30 of succeeding years, each affected licensing board shall certify the number of controlled substance registration certificates issued or renewed during the prior fiscal year. The certification shall be made to the Alabama Department of Public Health, Office of Professional and Support Services.
(4) Funds remitted to the Alabama Department of Public Health pursuant to this section shall be deposited into the Alabama State Controlled Substance Database Trust Fund. The funds shall be used exclusively for the development, implementation, operation, and maintenance of the controlled substances prescription database.
History
- Author: Charles C. Thomas, R.Ph., State Pharmacy Director
- Authority: Code of Ala. 1975, §§22-21-20, et. seq.
- New Rule: Filed February 18, 2005; effective March 25, 2005.
Ala. Admin. Code r. 420-7-2-.12 Prescription Drug Monitoring Program Reporting To Database By Dispensers
(1) Entities and practitioners that dispense controlled substances, Class II-V, shall report controlled substances prescription information to the Prescription Drug Monitoring Program database. These entities and practitioners include but are not limited to:
(a) Licensed pharmacies;
(b) Mail order pharmacies or pharmacy benefit programs filling prescriptions for or dispensing controlled substances to residents of Alabama; and
(c) Licensed physicians, dentists, podiatrists, and optometrists who dispense controlled substances.
(2) The reporting requirement in this rule does not apply to a controlled substance dispensed:
(a) By a pharmacy of a hospital, nursing home, or other inpatient health care facility if administered and used by a patient on the facility’s premises;
(b) By a practitioner if administered during the course of a patient’s treatment by injection, topical application, suppository administration, or oral administration; or
(c) By a practitioner as an appropriately labeled sample medication.
(3) Entities and practitioners shall submit reports as follows:
(a) Entities shall submit reports at least once daily by 11:59 p.m.
-
If an entity or practitioner does not dispense a controlled substance on a specific day, the entity or practitioner shall report that zero controlled substances were dispensed.
-
The daily reporting requirement does not apply on days that the entity or practitioner’s business is closed and no controlled substances are dispensed.
(b) Reports must be in electronic format according to American Society for Automation in Pharmacy Standards using the U.S. Postal Service’s Postal Addressing Standards.
-
If electronic transmission is not feasible, an entity or practitioner may request a waiver.
-
An entity or practitioner who receives a waiver may submit prescription information in an alternate format approved by the Prescription Drug Monitoring Program.
-
Entities and practitioners shall submit waiver requests and reports formatted pursuant to a valid waiver to:
Alabama Department of Public Health Prescription Drug Monitoring Program The RSA Tower, Suite 1010 P.O. Box 303017 Montgomery, AL 36130-3017 Fax: (334) 206-5663
- Penalties for noncompliance/non-reporting:
(a) On a monthly basis or as designated by the Prescription Drug Monitoring Program, licensing boards shall supply an electronic listing to the Prescription Drug Monitoring Program of entities and practitioners required to report controlled substances.
(b) The Prescription Drug Monitoring Program will monitor the list of entities and practitioners provided by the licensing boards for compliance in reporting to the database.
(c) The Department will notify the appropriate licensing board of an entity or practitioner’s failure to report. Upon notification of a non-reporting entity or practitioner, the relevant licensing board shall investigate and report to the Department the outcome.
History
- Author: Nancy Bishop, R. Ph., State Pharmacy Director
- Authority: Code of Ala. 1975, §22-21-20, et. seq.
- New Rule: Filed October 20, 2005; effective November 24, 2005. Amended: Filed February 17, 2006; effective March 24, 2006. Amended: Filed October 20, 2014; effective November 24, 2014. Amended: Filed August 19, 2016; effective October 3, 2016.
Ala. Admin. Code r. 420-7-2-.13 Access To Database
(1) Subject to the limitations provided in Section 20-2-214 of the Code of Ala. 1975, the following persons and entities may access the Prescription Drug Monitoring Program database:
(a) Authorized representatives of the certifying boards;
(b) Licensed practitioners who have the authority to prescribe, dispense, or administer controlled substances;
(c) Designated employees of a licensed physician if the physician has the authority to prescribe, dispense, or administer controlled substances;
(d) Licensed certified registered nurse practitioners, licensed certified nurse midwives, and licensed assistants to physicians who are authorized to prescribe, dispense, or administer controlled substances pursuant to a Qualified Alabama Controlled Substance Registration Certificate;
(e) Licensed pharmacists;
(f) Federal and Alabama law enforcement authorities;
(g) Authorized representatives of the Alabama Medicaid Agency; and
(h) Other persons listed in Section 20-2-214 of the Code of Ala. 1975.
(2) Law enforcement authorities shall pre-register with the Prescription Drug Monitoring Program to receive an ID and password to access a request form. To request a report from the Prescription Drug Monitoring Program, law enforcement authorities shall:
(a) Identify the specific individual or health care licensee that is the subject of the request;
(b) Certify that the request is pursuant to an active investigation; and
(c) Declare that probable cause exists for the use of the requested information.
History
- Author: Charles C. Thomas, R. Ph., State Pharmacy Director §
- Authority: Code of Ala. 1975, 22-21-20, et. seq.
- New Rule: Filed October 20, 2005; effective November 24, 2005. Amended: Filed July 19, 2007; effective August 23, 2007. Amended: Filed November 13, 2007; effective December 18, 2007. Amended: Filed October 20, 2014; effective November 24, 2014.
Ala. Admin. Code r. 420-7-2-A Appendix Controlled Substances List
ALABAMA STATE BOARD OF HEALTH
ALABAMA DEPARTMENT OF PUBLIC HEALTH
ADMINISTRATIVE CODE
APPENDIX
CONTROLLED SUBSTANCES LIST
Controlled Substances List
(Adopted by Alabama State Board of Health
on January 16, 2025, effective January 16, 2025)
Schedule I
(a) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.
(b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation (for purposes of 3-methylthiofentanyl only, the term isomer includes the optical and geometric isomers):
| 1. | Acetyl-alpha-methylfentanyl (N-[1-[1-methyl-2-phenethyl]-4-piperidinyl]-N-phenylacetamide (Federal Control Nov. 29, 1985; State Dec. 29, 1985) | 9815 |
|---|---|---|
| 2. | Acetylmethadol | 9601 |
| 3. | AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl] benzamide (Federal Control May 16, 2016; State June 15, 2016) | 9551 |
| 4. | Allylprodine | 9602 |
| 5. | Alphacetylmethadol | 9603 |
| 6. | Alphameprodine | 9604 |
| 7. | Alphamethadol | 9605 |
| 8. | Alpha-methylfentanyl (N-(l-(alpha-methyl-betaphenyl)ethyl-4-piperidyl) propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propenilido) piperidine) (Federal Control Sept. 22, 1981; State Oct. 22, 1981) | 9814 |
| 9. | Alpha-methylthiofentanyl (N-[1-methyl-2-[2-thienyl]ethyl-4-piperidinyl]N-phenylpropanamide) (Federal Control Nov. 29, 1985; State Dec. 29, 1985) | 9832 |
| 10. | Benzethidine | 9606 |
| 11. | Betacetylmethadol | 9607 |
| 12. | Beta-hydroxyfentanyl (N-[1-[2-hydroxy-2-phenethyl]-4-piperidinyl]-N-phenylpropanamide) (Federal Control Nov. 29, 1985; State Dec. 29, 1985) | 9830 |
| 13. | Beta-hydroxy-3-methylfentanyl(Other name: N-(1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl)-N-phenylpropanamide) (Federal Control Nov. 29, 1985; State Dec. 29, 1985) | 9831 |
| 14. | Betameprodine | 9608 |
| 15. | Betamethadol | 9609 |
| 16. | N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers (Other names: beta-hydroxythiofentanyl) (Federal Control May 12, 2016; State June 11, 2016) (Transferred Federal Control from Schedule I (n) to Schedule I (b) May 8, 2019; State Control June 7, 2019) | 9836 |
| 17. | Betaprodine | 9611 |
| 18. | Clonitazene | 9612 |
| 19. | Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide) (Federal Control Oct. 2, 2020; State Nov. 1, 2020) | 9844 |
| 20. | Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide) (Federal Control Nov. 25, 2020; State Dec. 25, 2020) | 9847 |
| 21. | Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide) (Federal Control Oct 25, 2019; State Nov. 24, 2019) | 9845 |
| 22. | Dextromoramide | 9613 |
| 23. | Diampromide | 9615 |
| 24. | Diethylthiambutene | 9616 |
| 25. | Difenoxin (Federal Control June 1, 1975; State July 1, 1975) | 9168 |
| 26. | Dimenoxadol | 9617 |
| 27. | Dimepheptanol | 9618 |
| 28. | Dimethylthiambutene | 9619 |
| 29. | Dioxaphetyl butyrate | 9621 |
| 30. | Dipipanone | 9622 |
| 31. | Ethylmethylthiambutene | 9623 |
| 32. | Etonitazene | 9624 |
| 33. | Etoxeridine | 9625 |
| 34. | Furethidine | 9626 |
| 35. | Hydroxypethidine | 9627 |
| 36. | Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyl-isobutyramide) (Federal Control Nov. 25, 2020; State Dec. 25, 2020) | 9827 |
| 37. | Isotonitazene (N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) (Federal Control Dec. 6, 2021; State Jan. 5, 2022) | 9614 |
| 38. | Ketobemidone | 9628 |
| 39. | Levomoramide | 9629 |
| 40. | Levophenacylmorphan | 9631 |
| 41. | Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) (Federal Control Oct. 25, 2019; State Nov. 24, 2019) | 9825 |
| 42. | 3-Methylfentanyl (N-[3-methyl-1-2-[phenylethyl]-4-piperidyl]-N-phenylpropanamide) (Federal Control April 25, 1985; State May 25, 1985) | 9813 |
| 43. | 3-Methylthiofentanyl (N-[3-methyl-1-[2-thienyl]ethyl-4-piperidinyl]-N-phenylpropanamide) (Federal Control Nov. 29, 1985; State Dec. 29. 1985) | 9833 |
| 44. | Morpheridine | 9632 |
| 45. | MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) (Transferred Federally Jan. 23, 1987; State Feb. 22, 1987) | 9661 |
| 46. | Noracymethadol | 9633 |
| 47. | Norlevorphanol | 9634 |
| 48. | Normethadone | 9635 |
| 49. | Norpipanone | 9636 |
| 50. | Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) propionamide) (Other names: 2-fluorofentanyl) (Federal Control Oct. 25, 2019; State Nov. 24, 2019) | 9816 |
| 51. | Para-chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(l-phenethyl-piperidin-4-y1)isobutyramide (Federal Control Nov. 25, 2020; State Dec. 25, 2020) | 9826 |
| 52. | Para-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(l-phenethylpiperidin-4-y1)butyramide) (Federal Control Oct. 25, 2019; State Nov. 24, 2019) | 9823 |
| 53. | Para-fluorofentanyl (N-[4-fluorophenyl]-N-[1-[2-phenethyl]-4-piperidinyl] Propanamide) (Federal Control Mar. 10, 1986; State April 9, 1986) | 9812 |
| 54. | Para-methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethyl-piperidin-4-yl)butyramide) (Federal Control Nov. 25, 2020; State Dec. 25, 2020) | 9837 |
| 55. | PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine) (Transferred Federally Jan. 23, 1987; State Feb. 22, 1987) | 9663 |
| 56. | Phenadoxone | 9637 |
| 57. | Phenampromide | 9638 |
| 58. | Phenomorphan | 9647 |
| 59. | Phenoperidine | 9641 |
| 60. | Piritramide | 9642 |
| 61. | Proheptazine | 9643 |
| 62. | Properidine | 9644 |
| 63. | Propiram | 9649 |
| 64. | Racemoramide | 9645 |
| 65. | Thiofentanyl (N-phenyl-N-[1-[2-thienyl]ethyl-4-piperidinyl]-propanamide) (Federal Control Nov. 29, 1985; State Dec. 29, 1985) | 9835 |
| 66. | Tilidine (Federal Control Dec. 1, 1980; State Dec. 31, 1980) | 9750 |
| 67. | Trimeperidine | 9646 |
| 68. | N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers (Other names: butyryl fentanyl) (Federal Control May 12, 2016; State June 11, 2016) (Transferred Federally from Schedule I (n) to Schedule I (b) April 20, 2018; State May 20, 2018) | 9822 |
| 69. | 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-Nmethylbenzamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers (Other name: U-47700) (Federal Control Nov. 14, 2016; State Dec. 14, 2016) (Transferred Federally from Schedule I (n) to Schedule I (b) April 20, 2018; State May 20, 2018) | 9547 |
| 70. | Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylacrylamide (Other name: acryloylfentanyl) (Federal Control Nov. 29, 2018; State Dec. 29, 2018) | 9811 |
| 71. | 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (Other name: parafluoroisobutyryl fentanyl) (Federal Control Nov. 29, 2018; State Dec. 29, 2018) | 9824 |
| 72. | Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylfuran-2-carboxamide) (Federal Control Nov. 29, 2018; State Dec. 29, 2018) | 9834 |
| 73. | Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)-acetamide) (Federal Control Nov. 29, 2018; State Dec. 29, 2018) | 9838 |
| 74. | Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenyltetra-hydrofuran-2-carboxamide) (Federal Control Nov. 29, 2018; State Dec. 29, 2018) | 9843 |
| 75. | Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyl-pentanamide) (Federal Control Nov. 25, 2020; State Dec. 25, 2020) | 9840 |
| 76. | N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide (2′-fluoro ortho-fluorofentanyl; 2′-fluoro 2-fluorofentanyl) (Federal Control April 27, 2021; State May 27, 2021) | 9856 |
| 77. | N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide (4′-methyl acetyl fentanyl) (Federal Control April 27, 2021; State May 27, 2021) | 9842 |
| 78. | N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide βphenyl fentanyl; beta′-Phenyl fentanyl; 3-phenylpropanoyl fentanyl) (Federal Control April 27, 2021; State May 27, 2021) | 9855 |
| 79. | N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide β-methyl fentanyl) (Federal Control April 27, 2021; State May 27, 2021) | 9819 |
| 80. | N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide (ortho-fluorobutyryl fentanyl; 2-fluorobutyryl fentanyl) (Federal Control April 27, 2021; State May 27, 2021) | 9846 |
| 81. | N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (ortho-methyl acetylfentanyl; 2-methyl acetylfentanyl) (Federal Control April 27, 2021; State May 27, 2021) | 9848 |
| 82. | 2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (ortho-methyl methoxyacetylfentanyl; 2-methyl methoxyacetyl fentanyl) (Federal Control April 27, 2021; State May 27, 2021) | 9820 |
| 83. | N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (para-methylfentanyl; 4-methylfentanyl)(Federal Control April 27, 2021; State May 27, 2021) | 9817 |
| 84. | N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide (phenyl fentanyl; benzoyl fentanyl) (Federal Control April 27, 2021; State May 27, 2021) | 9841 |
| 85. | N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide (thiofuranyl fentanyl; 2-thiofuranyl fentanyl; thiophene fentanyl) (Federal Control April 27, 2021; State May 27, 2021) | 9839 |
| 86. | Ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate (fentanyl carbamate) (Federal Control May 4, 2021; State June 3, 2021) | 9851 |
| 87. | N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide (ortho-fluoroacryl fentanyl) (Federal Control May 4, 2021; State June 3, 2021) | 9852 |
| 88. | N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) isobutyramide (ortho-fluoroisobutyryl fentanyl) (Federal Control May 4, 2021; State June 3, 2021) | 9853 |
| 89. | N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide (para-fluoro furanyl fentanyl) (Federal Control May 4, 2021; State June 3, 2021) | 9854 |
| 90. | Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol) (Federal Control Nov. 21, 2022; State Jan. 20, 2023) | 9873 |
| 91. | N,N-diethyl-2-[(4-methoxphenyl)methyl]5-nitro-1H-benzimidazole-1-ethanamine (Other name: Metonitazine) (State Control: Filed Dec. 15, 2022; Effective Feb. 13, 2023) | |
| 92. | Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1-,3-dihydro-2H-benzo[d]imidazol-2-one) (Federal Control April 5, 2023; State May 5, 2023) | 9098 |
| 93. | Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) (Federal Control Sept. 18, 2023; State Oct. 18, 2023) | 9757 |
| 94. | alpha′-Methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) (Federal Control Dec. 7, 2023; State Jan. 6, 2024) | 9864 |
| 95. | 2′,5′-Dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide)(Federal Control Dec. 7, 2023; State Jan. 6, 2024) | 9861 |
| 96. | 3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide) (Federal Control Dec. 7, 2023; State Jan. 6, 2024) | 9860 |
| 97. | isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) (Federal Control Dec. 7, 2023; State Jan. 6, 2024) | 9862 |
| 98. | meta-Fluorofentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)- propionamide) (Federal Control Dec. 7, 2023; State Jan. 6, 2024) | 9857 |
| 99. | meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1-phenethyl-piperidin-4-yl)isobutyramide) (Federal Control Dec. 7, 2023; State Jan. 6, 2024) | 9858 |
| 100. | ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) Federal Control Dec. 7, 2023; State Jan. 6, 2024) | 9863 |
| 101. | para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethyl-piperidin-4-yl)furan-2-carboxamide (Federal Control Dec. 7, 2023; State Jan. 6, 2024) | 9859 |
| 102. | para-Methylcyclopropyl fentanyl (N-(4-methylphenyl)-N-(1-phenethyl-piperidin-4-yl)cyclopropanecarboxamide) (Federal Control Dec. 7, 2023; State Jan. 6, 2024) | 9865 |
| 103. | 2-Methyl AP–237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one (Federal Control Apr. 15, 2024; State May 15, 2024) | 9664 |
| 104. | 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (Other names: etodesnitazene; etazene) (Federal Control Apr. 11, 2024; State May 11, 2024) | 9765 |
| 105. | 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino etonitazene; etonitazepyne) (Federal Control Apr. 11, 2024; State May 11, 2024) | 9758 |
| 106. | N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (Other name: protonitazene) (Federal Control Apr. 11, 2024; State May 11, 2024) | 9759 |
| 107. | N,N-diethyl-5-nitro-2-[(4-propoxyphenyl)methyl]-1H-benzimidazole-1-ethanamine (Protonitazene) Some trade or other names: Benzimidazole and 1-[2-(diethylamino)ethyl]-5-nitro-2-(p-propxybenzyl) (State Control: Filed May 16, 2024; Effective July 15, 2024) | |
| 108. | Butonitazene(2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (Federal Control Oct. 25, 2024; State Control Nov. 24, 2024) | 9751 |
| 109. | Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) (Federal Control Oct. 25, 2024; State Control Nov. 24, 2024) | 9756 |
| 110. | Metodesnitazene(N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine) (Federal Control Oct. 25, 2024; State Control Nov. 24, 2024) | 9764 |
| 111. | Beta-methylacetyl fentanyl(N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)acetamide) (Federal Control Sept. 18, 2025; State Control Oct. 18, 2025) | 9868 |
| 112. | Meta-fluorofuranyl fentanyl(N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) (Federal Control Sept. 18, 2025; State Control Oct. 18, 2025) | 9871 |
| 113. | Ortho-chlorofentanyl(N-(2-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (Federal Control Sept. 18, 2025; State Control Oct. 18, 2025) | 9828 |
| 114. | Ortho-methylcyclopropyl fentanyl(N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide) (Federal Control Sept. 18, 2025; State Control Oct. 18, 2025) | 9849 |
| 115. | Para-chlorofentanyl(N-(4-chlorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propanamide)Other name:(N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (State Control April 6, 2018)(Federal Control Sept. 18, 2025) | 9818 |
| 116. | Para-fluoro valeryl fentanyl(N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)pentanamide) (Federal Control Sept. 18, 2025; State Control Oct. 18, 2025) | 9870 |
| 117. | Tetrahydrothiofuranyl fentanyl(also known as: tetrahydrothiophene fentanyl)(N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrothiophene-2-carboxamide) (Federal Control Sept. 18, 2025; State Control Oct. 18, 2025) | 9869 |
| 118. | N-Desethyl isotonitazene(N-ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) (Federal Control Jan. 22, 2026; State Control Feb. 21, 2026) | 9760 |
| 119. | N-Piperidinyl etonitazene(2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1H-benzimidazole(Other name: etonitazepipne) (Federal Control Jan. 22, 2026; State Control Feb. 21, 2026) | 9761 |
| 120. | 2-(4-methoxybenzl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole(other names: N-pyrrolidino metonitazene; metonitazepyne) (Federal Control Feb. 11, 2026; State Control Mar. 13, 2026) | 9762 |
| 121. | 5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole(other names: N-pyrrolidino protonitazene; protonitazepyne) (Federal Control Feb. 11, 2026; State Control Mar. 13, 2026) | 9763 |
(c) Opium derivatives. Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
| 1. | Acetorphine | 9319 |
|---|---|---|
| 2. | Acetyldihydrocodeine | 9051 |
| 3. | Benzylmorphine | 9052 |
| 4. | Codeine methylbromide | 9070 |
| 5. | Codeine-N-Oxide | 9053 |
| 6. | Cyprenorphine | 9054 |
| 7. | Desomorphine | 9055 |
| 8. | Dihydromorphine | 9145 |
| 9. | Drotebanol | 9335 |
| 10. | Etorphine (except hydrochloride salt) | 9056 |
| 11. | Heroin | 9200 |
| 12. | Hydromorphinol | 9301 |
| 13. | Methyldesorphine | 9302 |
| 14. | Methyldihydromorphine | 9304 |
| 15. | Morphine methylbromide | 9305 |
| 16. | Morphine methylsulfonate | 9306 |
| 17. | Morphine-N-Oxide | 9307 |
| 18. | Myrophine | 9308 |
| 19. | Nicocodeine | 9309 |
| 20. | Nicomorphine | 9312 |
| 21. | Normorphine | 9313 |
| 22. | Pholcodine | 9314 |
| 23. | Thebacon | 9315 |
| 24. | Tianeptine (State Control Mar. 15, 2021) (Transferred State Control from Schedule II (c) to Schedule I (c) Nov. 14, 2021) |
(d) Hallucinogenic substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term "isomer" includes the optical, position, and geometric isomers):
| 1. | Alpha-ethyltryptamine, its optical isomers, salts and salts of isomers (Some trade or other names: etryptamine; Monase; α-ethyl-1H-indole-3- ethanamine; 3-(2-aminobutyl) indole; α-ET; and AET) (Federal Control Mar. 12, 1993; State Control April 11, 1993) | 7249 |
|---|---|---|
| 2. | 4-bromo-2,5-dimethoxyamphetamine (Some trade or other names: 4-bromo-2,5-dimethoxy-a-methylphenethy-lamine; 4-bromo-2,5-DMA) | 7391 |
| 3. | 4-bromo-2,5-dimethoxyphenethylamine (Some trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus) (Federal Control Jan. 6, 1994; State Feb. 5, 1994) | 7392 |
| 4. | 2,5-dimethoxyamphetamine (Some trade or other names: 2,5-dimethoxy-a-methyl-phenethylamine; 2,5-DMA) | 7396 |
| 5. | 2,5-dimethoxy-4-ethylamphetamine (Some trade or other names: DOET) (Federal Control Feb. 16, 1993; State Mar. 18, 1993) | 7399 |
| 6. | 2,5-dimethoxy-4-(n)-propylthiophenethylamine(2CT-7), its optical isomers, salts and salts of isomers (Federal Control Sept. 20, 2002; State Oct. 20, 2002) | 7494 |
| 7. | 4-methoxyamphetamine (Some trade or other names: 4-methoxy-a-methyl-phenethylamine; paramethoxyamphetamine; PMA) | 7411 |
| 8. | 5-methoxy-3, 4-methylenedioxy amphetamine | 7401 |
| 9. | 4-methyl-2,5-dimethoxy amphetamine (Some trade and other names: 4-methyl-2,5-dimethoxy-a-methylphenethy-lamine; "DOM" and "STP") | 7395 |
| 10. | 3,4-methylenedioxy amphetamine | 7400 |
| 11. | 3,4-methylenedioxymethamphetamine (MDMA) (Federal Control Mar. 23, 1988; State April 22, 1988) | 7405 |
| 12. | 3,4-methylenedioxy-N-ethylamphetamine (Also known as N-ethyl-alpha-methyl-3, 4 (methylenedioxy) phenethy-lamine, and N-ethyl MDA, MDE, MDEA) (Federal Control April 13, 1989; State May 13, 1989) | 7404 |
| 13. | N-hydroxy-3,4-methylenedioxyamphetamine (Also known as N-hydroxy-alpha-methyl-3, 4 (methylenedioxy) phenethylamine, and N-hydroxy MDA) (Federal Control April 13, 1989; State May 13, 1989) | 7402 |
| 14. | 3,4,5-trimethoxy amphetamine | 7390 |
| 15. | 5-methoxy-N,N-dimethyltryptamine (Some trade or other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT) | 7431 |
| 16. | Alpha-methyltryptamine (Other name: AMT) (Federal Control April 4, 2003; State May 4, 2003) | 7432 |
| 17. | Bufotenine (Some trade and other names: 3-(β-Dimethylamino-ethyl)- 5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,N-dimethyl-serotonin; 5-hydroxy N, N-dimethyltryptamine; mappine | 7433 |
| 18. | Diethyltryptamine (Some trade and other names: N,N-Diethyltryptamine; DET) | 7434 |
| 19. | Dimethyltryptamine (Some trade and other names: DMT) | 7435 |
| 20. | 5-methoxy-N,N-diisopropyltryptamine (Other name: 5-MeO-DIPT) (Federal Control April 4, 2003; State May 4, 2003) | 7439 |
| 21. | Ibogaine (Some trade and other names: 7-Ethyl-6,6β,7,8,9,10 12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido (1',2':1,2) azepino (5,4-b) indole; tabernatheiboga) | 7260 |
| 22. | Lysergic acid diethylamide | 7315 |
| 23. | Marihuana | 7360 |
| 24. | Mescaline | 7381 |
| 25. | Parahexyl (Some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6, 9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl) (Federal Control Dec. 22, 1982; State Jan. 21, 1983) | 7374 |
| 26. | Peyote Meaning all parts of the plant presently classified botanically as Lophophora Williamsii Lemaire, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture or preparation of such plant, its seeds or extracts. | 7415 |
| 27. | N-ethyl-3-piperidyl benzilate | 7482 |
| 28. | N-methyl-3-piperidyl benzilate | 7484 |
| 29. | Psilocybin | 7437 |
| 30. | Psilocyn | 7438 |
| 31. | Tetrahydrocannabinols Meaning tetrahydrocannabinols naturally contained in a plant of the genus cannabis (cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis plant, or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following: ∆1 cis or trans tetrahydrocannabinol, and their optical isomers. ∆6 cis or trans tetrahydrocannabinol, and their optical isomers. ∆3,4 cis or trans tetrahydrocannabinol, and its optical isomers. (Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered.) | 7370 |
| 32. | Ethylamine analog of phencyclidine (Some trade or other names: N-ethyl-1-phenylcycol-hexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE) (Federal Control Oct. 25, 1978; State Jan. 19, 1978) | 7455 |
| 33. | Pyrrolidine analog of phencyclidine (Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP) (Federal Control Oct. 25, 1978; State Nov. 24, 1978) | 7458 |
| 34. | Thiophene analog of phencyclidine (Some trade or other names: 1-(1-(2-thienyl) cyclohexyl) piperidine; 2-Thienyl Analog of Phencyclidine; TPCP) (Federal Control Aug. 11, 1975; State Sept. 10, 1975) | 7470 |
| 35. | 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (Some other names: TCPy) (Federal Control July 6, 1989; State Aug. 5, 1989) | 7473 |
| 36. | (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: UR-144, 1-pentyl-3-(2,2,3,3- tetramethylcyclopropoyl)indole) (Federal Control May 16, 2013; State Control June 16, 2013) (Transferred Federally from Schedule I(h) to Schedule I(d) May 11, 2016; State June 10, 2016) | 7144 |
| 37. | [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3- tetramethylcyclopropyl)methanone, its optical, positional, and geometric isomers, salts and salts of Isomers. (Other names: 5-fluoro-UR-144, 5-F-UR-144, XLR1l, 1-(5-fluoro-pentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)indole) (Federal Control May 16, 2013; State Control June 16, 2013) (Transferred Federally from Schedule I (h) to Schedule I (d) May 11, 2016; State June 10, 2016) | 7011 |
| 38. | N-(1-adamantyl)-1-pentyl-1Hindazole-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: APINACA, AKB48) (Federal Control May 16, 2013; State Control June 16, 2013) (Transferred Federally from Schedule I (h) to Schedule I (d) May 11, 2016; State June 10, 2016) | 7048 |
| 39. | Quinolin-8-yl 1-pentyl-lH-indole-3-carboxylate, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: PB-22; QUPIC) (Federal Control Feb. 10, 2014; State Control Mar. 10, 2014) (Transferred Federally from Schedule I (n) to Schedule In(d) Sept. 6, 2016; State Oct. 6, 2016) | 7222 |
| 40. | Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: 5-fluoro-PB-22; 5F-PB-22 (Federal Control Feb. 10, 2014; State Control Mar. 10, 2014) (Transferred Federally from Schedule I (n) to Schedule I (d) Sept. 6, 2016; State Oct. 6, 2016) | 7225 |
| 41. | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3- carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: AB-FUBINACA) (Federal Control Feb. 10, 2014; State Control Mar. 10, 2014) (Transferred Federally from Schedule I (n) to Schedule I (d) Sept. 6, 2016; State Oct. 6, 2016) | 7012 |
| 42. | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: ADB-PINACA) (Federal Control Feb. 10, 2014; State Control Mar. 10, 2014) (Transferred Federally from Schedule I (n) to Schedule I (d) Sept. 6, 2016; State Oct. 6, 2016) | 7035 |
| 43. | 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: 251-NBOMe; 2C-l-NBOMe; 251; Cimbi-5) (Federal Control Nov. 15, 2013; State Control Dec. 15, 2013) (Transferred Federally from Schedule I(n) to Schedule I(d) Oct. 27, 2016; State Nov. 26, 2016) | 7538 |
| 44. | 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: 25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82) (Federal Control Nov. 15, 2013; State Control Dec. 15, 2013) (Transferred Federally from Schedule I(n) to Schedule I(d) Oct. 27 2016; State Nov 26, 2016) | 7537 |
| 45. | 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: 25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36) (Federal Control Nov. 15, 2013; State Control Dec. 15, 2013) (Transferred Federally from Schedule I (n) to Schedule I (d) Oct. 27, 2016; State Nov. 26, 2016) | 7536 |
| 46. | Marihuana Extract. Meaning an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crude or purified) obtained from the plant (Federal Control Jan. 13, 2017; State Control Feb. 12, 2017) | 7350 |
| 47. | 4-methyl-N-ethylcathinone, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: 4-MEC; 2-(ethylamino)-1-(4-methylphenyl)propan-1-one) (Federal Control Mar. 7, 2014; State April 7, 2014) (Transferred Federally from Schedule I (n) to Schedule I (d) Mar. 1, 2017; State Mar. 31, 2017) | 1249 |
| 48. | 4-methyl-alphapyrrolidinopropiophenone, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: 4-MePPP; MePPP; 4-methyl-α-pyrrolidinopropiophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one) (Federal Control Mar. 7, 2014; State April 7, 2014) (Transferred Federally from Schedule I (n) to Schedule I (d) Mar. 1, 2017; State Mar. 31, 2017) | 7498 |
| 49. | Alpha-pyrrolidinopentiophenone, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: α-PVP; α-pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one) (Federal Control Mar. 7, 2014; State April 7, 2014) (Transferred Federally from Schedule I (n) to Schedule I (d) Mar. 1, 2017; State Mar. 31, 2017) | 7545 |
| 50. | Butylone, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: bk-MBDB; 1-(1,3-benzodioxol-5-yl)-2-(methylamino) butan-1-one) (Federal Control Mar. 7, 2014; State April 7, 2014) (Transferred Federally from Schedule I (n) to Schedule I (d) Mar. 1, 2017; State Mar. 31, 2017) | 7541 |
| 51. | Pentedrone, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: α-methylaminovalerophenone; 2-(methylamino)-1-phenyl-pentan-1-one) (Federal Control Mar. 7, 2014; State April 7, 2014) (Transferred Federally from Schedule I (n) to Schedule I (d) Mar. 1, 2017; State Mar. 31, 2017) | 1246 |
| 52. | Pentylone, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: bk-MBDP; 1-(1,3-benzodioxol-5-yl)-2-(methylamino) pentan-1-one) (Federal Control Mar. 7, 2014; State April 7, 2014) (Transferred Federally from Schedule I (n) to Schedule I (d) Mar. 1, 2017; State Mar. 31, 2017) | 7542 |
| 53. | 4-fluoro-N-methylcathinone, its optical, positional, and geometric isomers, salts and salts of isomers. (Other names: 4-FMC; flephedrone; 1-(4-fluorophenyl)-2-(methylamino) propan-1-one) (Federal Control Mar. 7, 2014; State April 7, 2014) (Transferred Federally from Schedule I (n) to Schedule I (d) Mar. 1, 2017; State Mar. 31, 2017) | 1238 |
| 54. | 3-fluoro-N-methylcathinone, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: 3-FMC; 1-(3-fluorophenyl)-2-(methylamino)propan-1-one) (Federal Control Mar. 7, 2014; State April 7, 2014) (Transferred Federally from Schedule I (n) to Schedule I (d) Mar. 1, 2017; State Mar. 31, 2017) | 1233 |
| 55. | Naphyrone, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: naphthylpyrovalerone; 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one) (Federal Control Mar. 7, 2014; State April 7, 2014) (Transferred Federally from Schedule I (n) to Schedule I (d) Mar. 1, 2017; State Mar. 31, 2017) | 1258 |
| 56. | Alpha-pyrrolidinobutiophenone, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: α-PBP; 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one) (Federal Control Mar. 7, 2014; State April 7, 2014) (Transferred Federally from Schedule I (n) to Schedule I (d) Mar. 1, 2017; State Mar. 31, 2017) | 7546 |
| 57. | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: AB-CHMINACA) (Transferred Federally from Schedule I (n) to Schedule I (d) Oct.16, 2017; State Nov. 15, 2017) | 7031 |
| 58. | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: AB-PINACA) (Federal Control Jan. 30, 2015; State Mar. 1, 2015) (Transferred Federally from Schedule I (n) to Schedule I (d) Oct.16, 2017; State Nov. 15, 2017) | 7023 |
| 59. | 1-(5-fluoropentyl)-1H-indazol-3-ylmethanone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: THJ-2201) (Federal Control Jan. 30, 2015; State Mar. 1, 2015) (Transferred Federally from Schedule I (n) to Schedule I (d) Oct.16, 2017; State Nov. 15, 2017) | 7024 |
| 60. | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-2carboxamide Other names: MABCHMINACA; ADBCHMINACA) (Federal Control Jan. 29, 2019; State Feb. 28, 2019) | 7032 |
| 61. | Methyl12-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethyl-butanoate (Other names: 5F-ADB; 5F-MDMB-PINACA) (Federal Control Jan. 24, 2020; State Feb. 23, 2020) | 7034 |
| 62. | Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methyl-butanoate (Other names: 5F-AMB) (Federal Control Jan. 24, 2020; State Feb. 23, 2020) | 7033 |
| 63. | N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other names: 5F-APINACA, 5F-AKB48) (Federal Control Jan. 24, 2020; State Feb. 23, 2020) | 7049 |
| 64. | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (Other names: ADB-FUBINACA) (Federal Control Jan. 24, 2020; State Feb. 23, 2020) | 7010 |
| 65. | Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB-CHMICA, MMBCHMINACA (Federal Control Jan. 24, 2020; State Feb. 23, 2020) | 7042 |
| 66. | Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethyl-butanoate (Other names: MDMB-FUBINACA) (Federal Control Jan. 24, 2020; State Feb. 23, 2020) | 7020 |
| 67. | Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (Other names: FUB—AMB, MMB—FUBINACA, AMB—FUBINACA) (Federal Control March 30, 2020; State April 29, 2020) | 7021 |
| 68. | Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (Other names: NM2201 or CBL2201) (Federal Control June 10, 2021; State July 10, 2021) | 7221 |
| 69. | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other name: 5F-AB-PINACA) (Federal Control June 10, 2021; State July 10, 2021) | 7025 |
| 70. | 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Other names: 4-CN-CUMYL-BUTINACA, 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, or SGT-78) (Federal Control June 10, 2021; State July 10, 2021) | 7089 |
| 71. | Methyl 2-(1-(cyclohexylmethy)-1H-indole-3-carboxamido)-3-methylbutanoate (Other names: MMB-CHMICA or AMB-CHMICA) (Federal Control June 10, 2021; State July 10, 2021) | 7044 |
| 72. | 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]-pyridine-3-carboxamide (Other name: 5F-CUMYL-P7AICA) (Federal Control June 10, 2021; State July 10, 2021) | 7085 |
| 73. | Methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethyl-butanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA) (Federal Control June 22, 2021; State July 22, 2021) | 7043 |
| 74. | N-ethylpentylone (Other names: ephylone, 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) (Federal Control June 14, 2021; State July 14, 2021) | 7543 |
| 75. | Methyl 3-methyl-2-{[(1-pentyl-1H-indazol-3-yl)carbonyl]amino}butanoate (Some trade or other names: AMB) (State Control Sept. 13, 2021) | |
| 76. | N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-(5-chloropentyl)-1H-indazole-3- carboxamide (Some trade or other names: 5-Chloro AB-PINACA) (State Control Sept. 13, 2021) | |
| 77. | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3- carboxamide (Some trade or other names: 5-Fluoro AB-PINACA) (State Control Sept. 13, 2021 | |
| 78. | N-(1-Amino-3,3-dimethyl-l-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3- carboxamide (Some trade or other names: 5-Fluoro ADB-PINACA) (State Control Sept. 13, 2021) | |
| 79. | 1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl-1H-indazole-3-carboxamide (Some trade or other names: 4-Cyano CUMYL-BUTINACA) (State Control Sept. 13, 2021) | |
| 80. | N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-(5-fluoropentyl)-1H-indole-3-carboxamide (Some trade or other names: 5-Fluoro ABICA, 5-Fluoro AB-PICA, MDA-2201, 5-Fluoro AMBICA (State Control Sept. 13, 2021) | |
| 81. | Methyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl] amino]-3,3-dimethyl-butanoate (Some trade or other names: 5-Fluoro MDMB-PICA) (State Control Sept. 13, 2021) | |
| 82. | Methyl (2s)-2-{[1-(4-fluorobutyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethyl-butanoate (Some trade or other names: 4-Fluoro-MDMB BUTINACA, 4-Fluoro MDMB-BINACA) (State Control Sept. 13, 2021) | |
| 83. | Methyl 3,3-dimethyl-2-(1-(pent-4-en-l-yl)-1H- indazole-3-carboxamido) butanoate (Some trade or other names: MDMB-4en-PINACA, MDMB-PENINACA, MDMB-PINACA N1-pentyl-4en isomer) (State Control Sept. 13, 2021) (Federal Control Apr. 27, 2026) | 7090 |
| 84. | 1-(4-Fluorobenzyl)-1H-indol-3-ylmethanone (Some trade or other names: FUB-144) (State Control Sept. 13, 2021) | |
| 85. | (Naphthalen-1-yl)(9-pentyl-9H-carbazol-3-yl) methanone (Some trade or other names: EG-018) (State Control Sept. 13, 2021) | |
| 86. | 1-(5-Fluoropentyl)-N-(quinolin-8-yl)-1H-indole-3-carboxamide (Some trade or other names: AM2201 8-Quinolinyl Carboxamide) (State Control Sept. 13, 2021) | |
| 88. | N,N-Dimethylpentylone (Some trade or other names: βk-DMBDP, Dipentylone) (State Control Sept. 13, 2021) | |
| 89. | N-Ethylpentylone (Some trade or other names: βk-EBDP, βk-ethyl-K, Ephylone, b-ketoethyl benzodioxolylpentanamine) (State Control Sept. 13, 2021) | |
| 90. | Methacryl fentanyl (State Control Sept. 13, 2021) | |
| 91. | Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethyl-butanoate (Some trade or other name: 5FEDMB-PINACA) (Federal Control April 7, 2022; State May 7, 2022) | 7036 |
| 92. | Methyl 2-(1-(5-fluoropentyl)-1Hindole-3-carboxamido)-3,3-dimethylbutanoate (Some trade or other names: 5FMDMB-PICA; 5F-MDMB-2201) (Federal Control April 7, 2022; State May 7, 2022) | 7041 |
| 93. | N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (Some trade or other names: FUB-AKB48; FUB-APINACA; AKB48 N-(4-Fluorobenzyl)) (Federal Control April 7, 2022; State May 7, 2022) | 7047 |
| 94. | 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Some trade or other names: 5F-CUMYL-PINACA; SGT-25) (Federal Control April 7, 2022) | 7083 |
| 95. | (l-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (Some trade or other name: FUB-144) (Federal Control April 7, 2022; State May 7, 2022) | 7014 |
| 96. | N-[(1S)-1-(aminocarbonyl)-2,2-dimethylpropyl]-1-butyl-1H-indazole-3-carboxamide (Some trade or other names: ADB-BUTINACA, 1-butyl-N-(1caramoyl-2,2-dimethyl-propyl)indazole-3-carboxamide) (State Control July 15, 2022) | |
| 97. | N-Ethylhexedrone (Some trade or other names: α-ethylaminohexanophenone; 2-(ethylamino)-1-phenylhexan-1-one) (Federal Control June 1, 2022; State July 1, 2022) | 7246 |
| 98. | alpha-Pyrrolidinohexanophenone (Some trade or other names: α-PHP; α-pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one) (Federal Control June 1, 2022; State July l, 2022) | 7544 |
| 99. | 4-Methyl-alpha-ethylaminopentiophenone (Some trade or other names: 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one) (Federal Control June 1, 2022; State July 1, 2022) | 7245 |
| 100. | 4’-Methyl-alpha-pyrrolidinohexiophenone (Some trade or other names: MPHP; 4’-methyl-alpha-pyrrolidinohexan-ophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one) (Federal Control June 1, 2022; State July 1, 2022) | 7446 |
| 101. | alpha-Pyrrolidinoheptaphenone (Some trade or other names; PV8; 1-phenyl-2-(pyrrolidine-1-yl)heptan-1-one) (Federal Control June 1, 2022; State July 1, 2022) | 7548 |
| 102. | 4’-Chloro-alpha-pyrrolidinovalerophenone (Some trade or other names: 4-chloro-α-PVP, 4’-chloro-α-pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)-pentan-1-one) (Federal Control June 1, 2022; State July 1, 2022) | 7443 |
| 103. | (2Z)-2-(1-hexyl-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazide, benzoic acid (MDA-19) (Some trade or other names: BZO-HEXOXIZID and N'-(1-Hexyl-2-oxoindolin-3-ylidene)benzohydrazide) (State Control: Filed July 20, 2023; Effective Sept. 14, 2023) | |
| 104. | N-(1,4-dimethylpentyl)-3,4-Dimethoxyamphetamine (Some trade or other name: N-(1,4-dimethylpentyl)-3,4-DMA) (State Control: Filed July 20, 2023; Effective Sept. 14, 2023) | |
| 105. | N-[[1-(5-fluoropentyl)-1H-indol-3-yl]carbonyl]-L-valine, ethyl ester (5-Fluoro EMB-PICA) (Some trade or other names: Ethyl (2S)-2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3-methyl-butanoate, EMB-2201, and 5F-EMB-PICA) (State Control: Filed July 20, 2023; Effective Sept. 14, 2023) | |
| 106. | Methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (4F-MDMB-BUTICA) (Some trade or other names: Methyl N-{[1-(4-fluorobutyl)-1H-indole-3-yl]carbonyl}- 3-methyl-L-valinate; Methyl 2-[1-(4-fluorobutyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoate; Methyl 2-{[1-(4-fluorobutyl)indol-3-yl]formamido}-3,3-dimethylbutanoate; Methyl 2-{[1-(4-fluorobutyl)-indole-3-carbonyl]amino}-3,3-dimethyl-butanoate; Methyl N-{[1-(4-fluorobutyl)-1H-indol-3-yl]carbonyl}-3-methyl-L-valinate; Methyl 2-{[1-(4-fluorobutyl)indol-3-yl]formamido}-3,3-dimethylbutanoate; MDMB-4F-BICA; 4F-MDMB-2201; MDMB-4F-BUTICA; 4F-MDMB-BUTICA; 4-Fluoro MDMB-BICA; 4-Fluoro MDMB-BUTICA; 4FBC; 4FBCA; and MDMB-073-F) (State Control: Filed July 20, 2023; Effective Sept. 14, 2023) (Federal Control May 1, 2026) | 7091 |
| 107. | Methyl (1-(5-Fluoropentyl)-1H-indole-3-carbonyl)-L-phenylalaninate (5F-MPP-PICA) (Some trade or other names: Methyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3-phenylpropanoate; MPHP-2201; 5-fluoro MPhP-PICA; and N-[[1-(5-fluoropentyl)-1H-indol-3-yl]carbonyl]-L-phenylalanine, methyl ester) (State Control: July 20, 2023; Effective Sept. 14, 2023) | |
| 108. | (S)-N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-hexyl-1H-indazole-3-carboxamide (ADB-HEXINACA) (Some trade or other names: ADB-HINACA and ADMB-HEXINACA) (State Control: Filed July 20, 2023; Effective Sept. 14, 2023) | |
| 109. | 1-(4-fluorophenyl)-2-(1-pyrrolidinyl)-1-hexanone (4'-fluoro-alpha-pyrrolidinohexanophenone) (Some trade or other names: 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)hexan-1-one; 4-fluoro-alpha-PHP; 4-F-alpha-PHP; 4-fluoro-alpha-pyrrolidinohexiophenone; 4-fluoro-PHP; 4-fluoro-PV-7; and 4'-fluoro-pyrrolidinohexanophenone) (State Control: Filed July 20, 2023; Effective Sept. 14, 2023) | |
| 110. | 1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)heptan-1-one (3,4-Methylenedioxy PV8) (Some trade or other names: 3,4-Methylenedioxy PV8; 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)heptan-1-one; 1-(1,3-Benzodioxole-5-yl)-2-pyrrolizino-1-heptanone; and 1-Heptanone, 1-(1,3-benzodioxol-5yl)-2-(1-pyrrolidinyl)) (State Control: Filed July 20, 2023; Effective Sept. 14, 2023) | |
| 111. | 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one (Some trade or other names: eutylone and bk-EBDB) (Federal Control April 10, 2023; State May 10, 2023) | 7549 |
| 112. | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide (Some trade or other name: ADB–BUTINACA) (Federal Control Dec. 13, 2023; State Jan. 12, 2024) | 7027 |
| 113. | 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (Some trade or other names: α-PiHP and alpha-PiHP) (Federal Control Dec. 13, 2023; State Jan. 12, 2024) | 7551 |
| 114. | 2-(methylamino)-1-(3-methylphenyl)propan-1-one (Some trade or other names: 3–MMC and 3-methylmethcathinone) (Federal Control Dec. 13, 2023; State Jan. 12, 2024) | 1259 |
| 115. | benzoic acid, (2Z)-2-(1,2-dihydro-2-oxo-1-pentyl-3H-indol-3-ylidene)hydrazide (Pentyl MDA-19) (Some trade or other names: BZO-POXIZID and 5C-MDA-19) (State Control: Filed May 16, 2024; Effective July 15, 2024) | |
| 116. | 4-methyl-1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (Alpha-Pyrrolidinoisohexanophenone) (Some trade or other names: a-PiHP; 4-Methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one, 4-Methyl-a-PVP, 4-Methyl-a-pyrrolidinopentanophenone, 4-Methyl-a-pyrrolidinopentiophenone, 4-Methyl-a-pyrrolidinavalerophenone,and 4-Methyl-desmethylpyrovalerone) (State Control: Filed May 16, 2024; Effective July 15, 2024) | |
| 117. | (Z)-N’-(2-oxo-1-(pent-4-en-1-yl)indolin-3-ylidene)benzohydrazide (BZO-4en-POXIZID) (Some trade or other names: 4en-pentyl MDA-19, MDA-19 4en-pentyl analogue, and N-[(Z)-(2-oxo-1-pent-4-enyl-indolin-3-ylidene)amino]benzamide) (State Control: Filed April 17, 2025; Effective June 14, 2025) | |
| 118. | (Z)-N’-(1-(5-fluoropentyl)-2-oxoindolin-3-ylidene)benzohydrazide (5F-BZO-POXIZID) (Some trade or other names: 5F-MDA-19, 5-fluoropentyl MDA 19, and N-[(Z)-[1-(5-fluoropentyl)-2-oxo-indolin-3-ylidene]amino]benzamide) (State Control: Filed April 17, 2025; Effective June 14, 2025) | |
| 119. | N-[(1S)-1-(aminocarbonyl)-2,2-dimethylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indole-3-acetamide (ADB-FUBIATA) (Some trade or other names: 2-[[2-[1-[(4-fluorophenyl)methyl]indol-3-yl]acetyl]amino]-3,3-dimethyl-butanamide, AD-18, and FUB-ACADB) (State Control: Filed April 17, 2025; Effective June 14, 2025) | |
| 120. | 1-(4-fluorobutyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide (4F-ABUTINACA) (Some trade or other names: N-(4-fluorobutyl) APINACA, 4-fluoro ABUTINACA, 4F-Adamantyl-BINACA, 4F-ABINACA, and N-(1-adamantyl)-1-(4-fluorobutyl)indazole-3-carboxamide) (State Control: Filed April 17, 2025; Effective June 14, 2025) | |
| 121. | (S)-N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-phenethyl-1H-indazole-3-carboxamide (ADB-PHETINACA)(Some trade or other names: ADB-PHTINACA and N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(2-phenylethyl)indazole-3-carboxamide) (State Control: Filed April 17, 2025; Effective June 14, 2025) | |
| 122. | (S)-N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-5-bromo-1H-indazole-3-carboxamide (ADB-5Br-INACA) (Some trade or other names: 5-bromo-N-(1-carbamoyl-2,2-dimethyl-propyl)-1H-indazole-3-carboxamide, 5Br-ADB-INACA, and ADB-5-Bromo-INACA) (State Control: Filed April 17, 2025; Effective June 14, 2025) | |
| 123. | N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(4-penten-1-yl)-1H-indazole-3-carboxamide (ADB-4en-PINACA) (Some trade or other names: N-(1-carbamoyl-2,2-dimethyl-propyl)-1-pent-4-enyl-indazole-3- carboxamide, ADMB-4en-PINACA, and ADB-PENINACA) (State Control: Filed April 17, 2025; Effective June 14, 2025) | |
| 124. | 1-[(4-fluorophenyl)methyl]-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indole-3-acetamide (AFUBIATA) (Some trade or other name: Adamantyl-FUBIATA) (State Control: Filed April 17, 2025; Effective June 14, 2025) | |
| 125. | 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylic acid, 1-naphthalenyl ester (FDU-PB22) (Some trade or other name: naphthalen-1-yl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate) (State Control: Filed April 17, 2025; Effective June 14, 2025) | |
| 126. | N-[(1-butyl-1H-indazol-3-yl)carbonyl]-3-methyl-L-valine, methyl ester (MDMB-BUTINACA) (Some trade or other names: methyl 2-[(1-butylindazole-3-carbonyl)amino]-3,3-dimethyl-butanoate and MDMB-BINACA) (State Control: Filed April 17, 2025; Effective June 14, 2025) | |
| 127. | N-[[1-(5-fluoropentyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine, ethyl ester (Some trade or other names: Ethyl 2-[[1-(5-fluoropentyl) indole-3-carbonyl] amino]-3,3-dimethyl-butanoate, 5-Fluoro-EDMB-PICA, 5F-EDMB-2201, and ETHYL 2-(1-(5-FLUOROPENTYL)-1H-INDOLE-3-CARBOXAMIDO)-3,3-DIMETHYLBUTANOATE, 5F-EDMB-PICA) (State Control: Filed April 17, 2025; Effective June 14, 2025) Federal Control May 1, 2026) | 7094 |
| 128. | 3-methyl-N-[(1-pentyl-1H-indazol-3-yl)carbonyl]-L-valine, ethyl ester (EDMB-PINACA)(Some trade or other name: Ethyl 3,3-dimethyl-2-[(1-pentylindazole-3-carbonyl)amino]butanoate) (State Control: Filed April 17, 2025; Effective June 14, 2025) | |
| 129. | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (Other names: dipentylone; N,N-dimethylpentylone) (Federal Control Sept. 7, 2025; State Oct. 7, 2025) | 7552 |
| 130. | (S)-N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-cyanobutyl)-1H-indole-3-carboxamide (4-Cyano AB BUTICA) (Other names: AB-4CN-BUTICA, 4CN-AB-BICA, and 4CN-AB-BUTICA) | |
| 131. | 1-(1,3-benzodioxol-5-yl)-2-(butylamino)-1-pentanone (N-Butyl Pentylone) (Other names: 1-(1,3-benzodioxol-5-yl)-2-(butylamino)pentan-1-one, 3,4-Methylenedioxy-α-butylaminopentiophenone, N-butylpentylone, bk-BBDP, bk-Butyl-K, and 3,4-Methylenedioxy-α-butylaminovalerophenone) | |
| 132. | 1-(1,3-benzodioxol-5-yl)-2-[(1-methylethyl)amino]-1-butanone (N-Isopropyl Butylone) (Other names: Isopropylbutylone, MDIPBP, 3,4-Methylenedioxy-α-Isopropylaminobutiophenone, and 3,4-Methylenedioxy-alpha-Isopropylaminobutiophenone) | |
| 133. | 1-(1,3-benzodioxol-5-yl)-2-(propylamino)-1-butanone (N-Propyl Butylone) (Other names: 1-(1,3-benzodioxol-5-yl)-2-(propylamino)butan-1-one, Putylone, bk-PBDB, Propylbutylone, 3,4-Methylenedioxy-α-Propylaminobutiophenone, and N-propyl Norbutylone) | |
| 134. | 1-(5-chloropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide (5-chloro AKB48) (Other names: N-(adamantan-1-yl)-1-(5-chloropentyl)-1H-indazole-3-carboxamide and 5-chloro APINACA) | |
| 135. | Methyl (S)-2-(5-bromo-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (MDMB-5Br-INACA) (Other names: Methyl 2-[(5-bromo-1H-indazole-3-carbonyl)amino]-3,3-dimethyl-butanoate, MDMB-5-bromo-INACA, and 5Br-MDMB-INACA) | |
| 136. | N-[(1S)-1-(aminocarbonyl)-2,2-dimethylpropyl]-1H-indazole-3-carboxamide (ADB-INACA) (Other name: N-(carbamoyl-2,2-dimethyl-propyl)-1H-indazole-3-carboxamide) | |
| 137. | N-(1H-indazol-3-ylcarbonyl)-3-methyl-L-valine, methyl ester (MDMB-INACA) (Other name: Methyl 2-(1H-indazole-3-carbonylamino)-3,3-dimethyl-butanoate) | |
| 138. | 4-Chloromethcathinone (4–CMC, 1-(4-chlorophenyl)-2-(methylamino)propan-1-one) (Federal Control Dec. 17, 2025; State Jan. 16, 2026) | 1239 |
| 139. | 1-pentyl-3-(1-naphthoyl)indole(JWH-018 and AM678) (Federal Control Mar. 1, 2011; State Mar. 31, 2011) (Transferred Federally from Schedule I(h) to Schedule I(g) Jan. 4, 2013; State Feb. 4, 2013) (Transferred Federally from Schedule I(g) to Schedule (d) Feb. 19, 2026; State Mar. 19, 2026) | 7118 |
| 140. | 1-(5-fluoropentyl)-3-(1-naphthoyl)indole(AM2201)(Transferred Federally from Schedule I(h) to Schedule I(g) Jan. 4, 2013; State Feb. 4, 2013) (Transferred Federally from Schedule I(g) to Schedule (d) Feb. 19, 2026; State Mar. 19, 2026) | 7201 |
| 141. | 3-Methoxyphencyclidine (Other names: 1-(1-(3-methocyphenyl)cyclohexyl)piperidine; 3-MeO--PCP) (State Control Mar. 18, 2014) (Federal Control Apr. 22, 2006) | 7457 |
| 142 | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide (other name: ADB-4en-PINACA) (Federal Control May 1, 2026; State May 31, 2026) | 7092 |
| 143 | Methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methyl butanoate (other name: MMB-FUBICA) (Federal Control May 1, 2026; State Control May 31, 2026) | 7095 |
| 144 | 6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol (other names: hexahydrocannabinol, HHC) (Federal Control May 4, 2026; State Jun. 3, 2006 | 7220 |
| 145 | 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one (other names: CUMYL-PEGACLONE; SGT-151) (Federal Control May 13, 2026; State June 12, 2006) | 7093 |
(e) A synthetic controlled substance that is any material, mixture, or preparation that contains any quantity of the following chemical compounds, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation or compound:
| 1. | (2-Methyl-1-pentyl-1H-indol-3-yl)-1-naphthalenyl-methanone (Some trade or other names: JWH-007) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
|---|---|---|
| 2. | (2-Methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone (Some trade or other names: JWH-015) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 3. | (1-Pentyl-1H-indol-3-yl)-1-naphthalenyl-methanone (Some trade or other names: JWH-018) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 4. | (1-Hexyl-1H-indol-3-yl)-1-naphthalenyl-methanone (Some trade or other names: JWH-019) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 5. | (1-Butyl-1H-indol-3-yl)-1-naphthalenyl-methanone (Some trade or other names: JWH-073) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 6. | (1-Penty-1H-lindol-3-yl)-4-Methoxynaphthalen-1-yl-methanone (Some trade or other names: JWH-081) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 7. | (1-Pentyl-2-methyl-1H-indol-3-yl)-4-Methoxynaphthalen-1-yl-methanone (Some trade or other names: JWH-098) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 8. | (1-Pentyl-1H-indol-3-yl)-4-methylnaphthalen-1-yl-methanone (Some trade or other names: JWH-122) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 9. | [1-(2-(4-Morpholinyl)ethyl]-1H-indol-3-yl]-1-naphthalenyl-methanone (Some trade or other names: JWH-200) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 10. | (1-Pentyl-1H-lindol-3-yl)-2-(2-Chlorophenyl)-ethanone (Some trade or other names: JWH-203) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 11. | (1-Pentyl-1H-indol-3-yl)-1-(4-Ethylnaphthalenyl)-methanone (Some trade or other names: JWH-210) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 12. | (1-Pentyl-lH-lindol-3-yl)-2-(2-Methoxyphenyl)-ethanone (Some trade or other names: JWH-250) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 13. | (5-(2-fluorophenyl)-1-pentylpyrrol-3-yl)-naphthalen-1- ylmethanone (Some trade or other names: JWH-307) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 14. | (1-Pentyl-1H-indol-3-yl)-1-(4-chloronaphthalen-1-yl)-methanone (Some trade or other names: JWH 398) (ALREADY ON AL CSL) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 15. | 1-Pentyl-3-(4-Chloro-1-naphthoyl)indole (Some trade or other names: JWH-398) | |
| 16. | (R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo [1,2,3-de]-1, 4-benzoxazin-6-yl]-1-napthalenylmethanone (Some trade or other names: WIN 55,212-2) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 17. | (4-Methoxyphenyl)-[2-methyl-1-(2-morpholin-4-ylethyl)-1H-indol-3-yl]methanone (Some trade or other names: WIN 48,098, Pravadoline) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 18. | 2-(2-Methoxyphenyl)-1-[1-(2-cyclohexylethyl)-1H-indol-3-yl]ethanone (Some trade or other names: RCS-8, SR-18) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 19. | 2-(4-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)methanone (Some trade or other names: RCS-4) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 20. | (6aR, 10aR)-9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (Some trade or other names: HU-210) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 21. | (6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (Some trade or other names: HU-211, Dexanabinol) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 22. | 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol (Some trade or other names: CP 47, 497) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 23. | 1-[(5-fluoropentyl)-1H-indol-3-yl]-1-(2-iodophenyl)methanone (Some trade or other names: AM-694) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 24. | 1-[(5-fluoropentyl)-1H-indol-3-yl]-1-(naphthalen-1-yl)methanone (Some trade or other names: AM-2201) (State Control; Emergency Order Filed Oct. 14, 2011; Effective Oct. 24, 2011; Final adoption filed Dec. 21, 2011; Effective Jan. 25, 2012) | |
| 25. | 3-Fluoromethcathinone (Some trade or other names: 3-FMC) (State Control May 10, 2012) | |
| 26. | 4-Fluoromethcathinone (Flephedrone) (Some trade or other names: 4-FMC) (State Control May 10, 2012) | |
| 27. | 4-Methoxymethcathinone (Some trade or other names: bk-PMMA) (State Control May 10, 2012) | |
| 28. | 4-Methylmethcathinone (Mephedrone) (Some trade or other names: 4-methylephedrone) (Federal Control Jan. 4, 2013; State Feb. 3, 2013) | 1248 |
| 29. | 3,4—Methylenedioxypyrovalerone (MDPV) (Federal Control Jan. 4, 2013; State Feb. 3, 2013) | 7535 |
| 30. | 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C—E) (Federal Control Jan. 4, 2013; State Feb. 3, 2013) | 7509 |
| 31. | 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C—D) (Federal Control Jan. 4, 2013; State Feb. 3, 2013) | 7508 |
| 32. | 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C—C) (Federal Control Jan. 4, 2013; State Feb. 3, 2013) | 7519 |
| 33. | 2-(4-lodo-2,5-dimethoxyphenyl)ethanamine (2C—I) (Federal Control Jan. 4, 2013; State Feb. 3, 2013) | 7518 |
| 34. | 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C—T—2) (Federal Control Jan. 4, 2013; State Feb. 3, 2013) | 7385 |
| 35. | 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C—T—4) (Federal Control Jan. 4, 2013; State Feb. 3, 2013) | 7532 |
| 36. | 2-(2,5-Dimethoxyphenyl)ethanamine (2C—H) (Federal Control Jan. 4, 2013; State Feb. 3, 2013) | 7517 |
| 37. | 2-(2,5-Dimethoxy-4-nitrophenyl)ethanamine (2C—N) (Federal Control Jan. 4, 2013; State Feb. 3, 2013) | 7521 |
| 38. | 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C—P) (Federal Control Jan. 4, 2013; State Feb. 3, 2013) | 7524 |
| 39. | (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl) methanone (Some trade or other names: UR-144) (State Control: Filed April 12, 2013; Effective May 12, 2013) | |
| 40. | 2-iodophenyl-(1-(1-methylpiperidin-2-ylmethyl)-1H-indol-3-yl)methanone (Some trade or other names: AM-2233) (State Control: Filed April 12, 2013; Effective May 12, 2013) | |
| 41. | 3-4-Methylenedioxymethcathinone (Methylone) (Some other names: 3,4-methylenedioxy-N-methylcathinone) (Federal Control Jan. 4, 2013; State Feb. 4, 2013) (Transferred Federally from Schedule I (h) to Schedule I (d) April 12, 2013; State May 12, 2013) | 7540 |
| 42. | 2-(Ethylamino)-1-(3-fluorphenyl)-1-propanone (Some other names: 3-Fluoroethcathinone, 3-FEC, 1-Propanone, and 2-(ethylamino)-1-(3-fluorophenyl) (State Control: Filed Dec. 15, 2022; Effective Feb. 13, 2023) | |
| 43. | 2-(Ethylamino)-1-phenyl-1-pentanone (Some other names: N-Ethylnorpentedrone, a-ethylaminopentiophenone, a-EAPP, a-ethylaminovalerophenone, NEP, and N-ethylpentedrone) (State Control: Filed Dec. 15, 2022; Effective Feb. 13, 2023) | |
| 44. | 1-(1,3-benzodioxol-5-yl)-2-(cyclohexylamino)-1-propanone (N-Cyclohexyl Methylone) (Other names: 1-(1,3-benzodioxol-5-yl)-2-(cyclohexylamino)propan-1-one, Cyputylone, 3,4-Methylenedioxy-N-Cyclohexylcathinone, and 3,4-Methylenedioxy-α-Cyclohexylaminopropiophenone) |
(f) In addition to any material, mixture, or preparation that contains any quantity of the chemical compounds listed in paragraph (e), a synthetic controlled substance also includes the following chemical compounds, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation or compound:
| 1. | 1-[(N-methylpiperidin-2-yl)methyl]-3-(2-iodobenzoyl)indole (Some trade or other names: AM-2233) (State Control Mar. 18, 2014) | |
|---|---|---|
| 2. | 1-Pentyl-3-(1-adamantoyl)indole (Some trade or other names: AB00l) (State Control Mar. 18, 2014) | |
| 3. | [1-[(1-methyl-2-piperidinyl)methyl]-1H-indo1-3-yl]-1- naphthalenyl-methanone (Some trade or other names: AM1220) (State Control Mar. 18, 2014) | |
| 4. | 1-(5-Fluoropentyl)-3-(2,2,3,3-tetramethylcyclopropyoyl)indole (Some trade or other names: XLRl1) (State Control Mar. 18, 2014) | |
| 5. | 1-Pentyl-3-(2,2,3,3-tetramethycyclopropoyl)indole (Some trade or other names: UR-144) (State Control Mar. 18, 2014) | |
| 6. | 6-Methyl-2[(4-methylphenyl)amino]-4H-3,1-benzoxazin-4-one (Some trade or other names: URB 754) (State Control Mar. 18, 2014) | |
| 7. | [1,1'-biphenyl]-3-yl-carbamic acid, cyclohexyl ester (Some trade or other names: URB 602) (State Control Mar. 18, 2014) | |
| 8. | (3'-(Aminocarbonyl)[1,1'-biphenyl]-3-yl)-cyclohexylcarbamate (Some trade or other names: URB597) (State Control Mar. 18, 2014) | |
| 9. | 1-(5-Fluoropentyl)-3-(4-methyl-1-naphthoyl)indole (Some trade or other names: MAM2201) (State Control Mar. 18, 2014) | |
| 10. | 1-naphthalenyl[4-(pentyloxy)-naphthaleny1]methanone (Some trade or other names: CB-13) (State Control Mar. 18, 2014) | |
| 11. | 1-(5-Chloropentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)indole (Some trade or other names: 5-Chloro-UR-144) (State Control Mar. 18, 2014) | |
| 12. | 1-(5-Fluoropentyl)-N-tricyclo[3,3,1,13,7]dec-1-yl-1H-indole-3-carboxamide (Some trade or other names: STS-135) (State Control Mar. 18, 2014) | |
| 13. | 1[(N-Methylpiperidin-2-yl)methyl]-3-(adamant-1-oyl)indole (Some trade or other names: AM1248) (State Control Mar. 18, 2014) | |
| 14. | N-Adamantyl-1-pentyl-1H-indole-3-carboxamide (Some trade or other names: SDB-001, 2NE1) (State Control Mar. 18, 2014) | |
| 15. | l-Pentyl-N-tricyclo[3,3,1,13,7]dec-1-yl-1H-indazole-3-carboxamide (Some trade or other names: AKB48, APINACA) (State Control Mar. 18, 2014) | |
| 16. | 3-Napthoylindole (State Control Mar. 18, 2014) | |
| 17. | 1-[2-(4-Morpholinyl)ethy1]-3-(2,2,3,3-tetramethyl cyclopropyl)indole (Some trade or other names: A 796, 260) (State Control Mar. 18, 2014) | |
| 18. | 1-[(tetrahydropyran-4-ylmethyl)-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone (Some trade or other names: A834, 735) (State Control Mar. 18, 2014) | |
| 19. | 1-(Pent-4-en-1-yl)-3-(4-methyl-1-naphthoyl)indole (Some trade or other names: JWH-122 4-pentenyl analog) (State Control Mar. 18, 2014) | |
| 20. | N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(4- fluorophenyl)methyl]-1H indazole-3-carboxamide (Some trade or other names: AB-FUBINACA) (State Control Mar. 18, 2014) | |
| 21. | [1-(5-bromopentyl)-1H-indol-3-yl](2,2,3,3-tetramethyl cyclopropyl)methanone (Some trade or other names: 5-Bromo-UR-144) (State Control Mar. 18, 2014) | |
| 22. | 1-(5-Fluoropentyl)-N-tricyclo[3,3,1,13,7]dec-1-yl-1H-indazole-3-carboxamide (Some trade or other names: 5F-AKB48, 5F-APINACA) (State Control Mar. 18, 2014) | |
| 23. | 1-(penta-4-ene)-3-(1-naphthoyl)indole (Some trade or other names: JWH-022) (State Control Mar. 18, 2014) | |
| 24. | 1-(5-Chloropentyl)-3-(1-naphthoyl)indole (Some trade or other names: Chloro-AM-2201, JWH-018 N-5-chloropentyl analog) (State Control Mar. 18, 2014) | |
| 25. | 1-(5-Hydroxypentyl)-3-(1-naphthoyl)indole (Some trade or other names: Hydroxy-AM-2201) (State Control Mar. 18, 2014) | |
| 26. | N-[(2E)-3-(2-Methoxyethyl)4,5-dimethyl-1,3-thiazole-2(3H)-ylid ene]-2,2,3,3-tetramethylcyclopropane carboxamide (Some trade or other names: A 836, 339) (State Control Mar. 18, 2014) | |
| 27. | 1-Pentyl-3-(2-iodobenzoyl)indole (Some trade or other names: AM 679) (State Control Mar. 18, 2014) | |
| 28. | 1-Pentyl-3-(2-methylphenacetyl)indole (Some trade or other names: (JWH-251) (State Control Mar. 18, 2014) | |
| 29. | 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester (Some trade or other names: PB-22, QUPIC) (State Control Mar. 18, 2014) | |
| 30. | 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester (Some trade or other names: 5F-PB-22) (State Control Mar. 18, 2014) | |
| 31. | 1-pentyl-N-(napthalen-1-yl)-1H-indole-3-carboxamide (Some trade or other names: MN-24, NNE1) (State Control Mar. 18, 2014) | |
| 32. | 1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester (Some trade or other names: BB-22, QUCHIC) (State Control Mar. 18, 2014) | |
| 33. | N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide (Some trade or other names: AB-PINACA) (State Control Mar. 18, 2014) | |
| 34. | 7-methoxy-1-(2-morpholinoethyl)-N-((1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1] heptan-2-yl)-1H-indole-3-carboxamide (Some trade or other names: MN-25) (State Control Mar. 18, 2014) | |
| 35. | ADB-PINACA (State Control Mar. 18, 2014) | |
| 36. | FUB-AKB-48 (State Control Mar. 18, 2014) | |
| 37. | FUB-PB-22 (State Control Mar. 18, 2014) | |
| 38. | Heptyl-UR144 (State Control Mar. 18, 2014) | |
| 39. | THJ-018 (State Control Mar. 18, 2014) | |
| 40. | THJ-2201 (State Control Mar. 18, 2014) | |
| 41. | 1-heptyl-3-(1-napthoyl)indole) (Some trade or other names: JWH-20) (State Control Mar. 18, 2014) | |
| 42. | Napthalen-1-yl-(1-propyl-1H-indol-3-yl)methanone (Some trade or other names: JWH-072) (State Control Mar. 18, 2014) | |
| 43. | (6aR,10aR)-3-(1,1-Dimethylbutyl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran (Some trade or other names: JWH-133) (State Control Mar. 18, 2014) | |
| 44. | 3-(napthalen-1-ylmethyl)-1-pentyl-1H-indole (Some trade or other names: JWH-175) (State Control Mar. 18, 2014) | |
| 45. | 1-pentyl-3-(4-methoxyophenylacetyl)indole (Some trade or other names: JWH-201) (State Control Mar. 18, 2014) | |
| 46. | 1-pentyl-3-(3-methoxyphenylacetyl)indole (Some trade or other names: JWH 302) (State Control Mar. 18, 2014) | |
| 47. | [(1R,2R,5R)-2-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]methanol (Some trade or other names: HU-308) (State Control Mar. 18, 2014) | |
| 48. | 3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-penty1-2,5-cyclohexadiene-1,4-dione (Some trade or other names: HU-331) (State Control Mar. 18, 2014) | |
| 49. | N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-undecanamide (Some trade or other names: CB-25) (State Control Mar. 18, 2014) | |
| 50. | N-cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-undecanamide (Some trade or other names: CB-52) (State Control Mar. 18, 2014) | |
| 51. | 2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol (Some trade or other names: CB-55, 940) (CB-55) (State Control Mar. 18, 2014) | |
| 52. | 4-Methylethylcathinone (Some trade or other names: 4-MEC, 4-Methylethcathinone) (State Control Mar. 18, 2014) | |
| 53. | 4'-Methyl-alpha-pyrrolidinopropiophenone (Some trade or other names: MPPP, ZZ-1) (State Control Mar. 18, 2014) | |
| 54. | (RS)-1-naphthalen-2-yl-2-pyrrolidin-1-ylpentan-1-one (Some trade or other names: Naphyrone) (State Control Mar. 18, 2014) | |
| 55. | alpha,alpha-Diphenyl-2-piperidinemethanol (Some trade or other names: Pipradrol, Meratran) (State Control Mar. 18, 2014) | |
| 56. | (RS)-1-(4-methylphenyl)-2-(1-pyrrolidinyl)pentan-1-one (Some trade or other names: Pyrovalerone) (State Control Mar. 18, 2014) | |
| 57. | 3,4-Dimethylmethcathinone (Some trade or other names: 3,4-DMMC) (State Control Mar. 18, 2014) | |
| 58. | 4-Fluoroamphetamine (Some trade or other names: 4-FA) (State Control Mar. 18, 2014)(Fed Control Feb. 17, 2026) | |
| 59. | 4-Fluoromethamphetamine (Some trade or other names: 4-FMA) (State Control Mar. 18, 2014) | |
| 60. | Butylone (Some trade or other names: bk-MBDB) (State Control Mar. 18, 2014) | |
| 61. | alpha-Pyrrolidinopentiophenone (Some trade or other names: alpha-PVP) (State Control Mar. 18, 2014) | |
| 62. | beta-keto-Dimethylbenzodioxolylbutanamine (Some trade or other names: bk-DMBDB) (State Control Mar. 18, 2014) | |
| 63. | 2-(methylamino)-1-phenylbutan-1-one (Some trade or other names: Buphedrone) (State Control Mar. 18, 2014) | |
| 64. | (RS)-2-ethylamino-1-phenyl-propan-1-one (Some trade or other names: N-Ethylcathinone) (State Control Mar. 18, 2014) | |
| 65. | 2-Fluoroamphetamine (Some trade or other names: 2-FA) (State Control Mar. 18, 2014) | |
| 66. | Methoxetamine (Some trade or other names: MXE) (State Control Mar. 18, 2014) (Federal Control July 6, 2022) | 7286 |
| 67. | 2-Methylamino-1-phenylpentan-1-one (Some trade or other names: Pentedrone) (State Control Mar. 18, 2014) | |
| 68. | 3,4-Methylenedioxycathinone (Some trade or other names: MDC) (State Control Mar. 18, 2014) | |
| 69. | 2-Fluoromethamphetamine (Some trade or other names: 2-FMA) (State Control Mar. 18, 2014) | |
| 70. | 4-methylmethamphetamine (Some trade or other names: 4-MMA) (State Control Mar. 18, 2014) | |
| 71. | 4-Fluoroisocathinone (Some trade or other names: 4-FIC) (State Control Mar. 18, 2014) | |
| 72. | 3-Fluoromethamphetamine (Some trade or other names: 3-FMA) (State Control Mar. 18, 2014) | |
| 73. | Methiopropamine (Some trade or other names: MPA) (State Control Mar. 18, 2014) (Federal Control Jan. 9, 2023) | 1478 |
| 74. | alpha-Pyrrolidinobutiophenone (Some trade or other names: alpha-PBP) (State Control Mar. 18, 2014) | |
| 75. | 4-Methoxy-N-methylcathinone (Some trade or other names: Methedrone, bk-PMMA) (State Control Mar. 18, 2014) | |
| 76. | alpha-Pyrrolidinopropiophenone (Some trade or other names: alpha-PPP) (State Control Mar. 18, 2014) | |
| 77. | (RS)-2-benzhydrylpiperidine (Some trade or other names: Desoxypipradrol) (State Control Mar. 18, 2014) | |
| 78. | 3,4-Methylenedioxyethylcathinone (Some trade or other names: MDEC) (State Control Mar. 18, 2014) | |
| 79. | 3,4-Methylenedioxy-alpha-pyrrolidinobutiophenone (Some trade or other names: MDPBP) (State Control Mar. 18, 2014) | |
| 80. | 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (Pentylone, bk-MBDP) (State Control Mar. 18, 2014) | |
| 81. | 3-Fluoroamphetamine (Some trade or other names: 3-FA) (State Control Mar. 18, 2014) | |
| 82. | 3-Fluoromethcathinone (Some trade or other names: 3-FMC) (State Control Mar. 18, 2014) | |
| 83. | 2-Fluoromethcathinone (Some trade or other names: 2-FMC) (State Control Mar. 18, 2014) | |
| 84. | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)propan-1-one (bk-MDDMA) (State Control Mar. 18, 2014) | |
| 85. | N,N-Diethylcathinone (Some trade or other names: Amfepramone, DEC) (State Control Mar. 18, 2014) | |
| 86. | 1,3-Dimethylamylamine (Some trade or other names: DMAA) (State Control Mar. 18, 2014) | |
| 87. | N, N-Dimethylcathinone (Some trade or other names: DMC) (State Control Mar. 18, 2014) | |
| 88. | N-Ethyl-3,4-methylenedioxycathinone (Some trade or other names: bk-MDEA) (State Control Mar. 18, 2014) | |
| 89. | N-Ethylamphetamine (Some trade or other names: EMA) (State Control Mar. 18, 2014) | |
| 90. | N-Ethylcathinone (Some trade or other names: EC) (State Control Mar. 18, 2014) | |
| 91. | 2-Ethylethcathinone (Some trade or other names: 2-EEC) (State Control Mar. 18, 2014) | |
| 92. | 4-Ethyl-N-ethylcathinone (Some trade or other names: 4-EEC) (State Control Mar. 18, 2014) | |
| 93. | 2-(5-Methoxy-1-benzofuran-3-yl)-N,N-dimethylethanamine (Some trade or other names: Dimembfe) (State Control Mar. 18, 2014) | |
| 94. | 2-(5-Methoxy-1-benzofuran-3-yl)N-ethylethamine (State Control Mar. 18, 2014) | |
| 95. | 4-Methoxymethamphetamine (Some trade or other names: PMMA) (State Control Mar. 18, 2014) | |
| 96. | 4-Methoxy-N-ethylamphetamine (Some trade or other names: PMEA) (State Control Mar. 18, 2014) | |
| 97. | 4-Methoxy-N-ethylcathinone (Some trade or other names: ETHEDRONE) (State Control Mar. 18, 2014) | |
| 98. | 3-Methylmethcathinone (Some trade or other names: 3-MMC) (State Control Mar. 18, 2014) | |
| 99. | 4-Methyl-alpha-pyrrolidinobutiophenone (Some trade or other names: MPBP) (State Control Mar. 18, 2014) | |
| 100. | 2-Methylethcathinone (Some trade or other names: 2-MEC) (State Control Mar. 18, 2014) | |
| 101. | 3-Methylethcathinone (Some trade or other names: 3-MEC) (State Control Mar. 18, 2014) | |
| 102. | 2-Ethylethcathinone (Some trade or other names: 2-EEC) (State Control Mar. 18, 2014) | |
| 103. | 3-Ethylethcathinone (Some trade or other names: 3-EEC) (State Control Mar. 18, 2014) | |
| 104. | 3-Ethylmethcathinone (Some trade or other names: 3-EMC) (State Control Mar. 18, 2014) | |
| 105. | 3',4'-Methylenedioxy-alpha-pyrrolidinopropiophenone (Some trade or other names: MDPPP) (State Control Mar. 18, 2014) | |
| 106. | alpha-Pyrrolidinopentiothiophenone (Some trade or other names: alpha-PVT) (State Control Mar. 18, 2014) | |
| 107. | 3-Methoxymethcathinone (Some trade or other names: 3-MeOMC) (State Control Mar. 18, 2014) | |
| 108. | N-Methyl-1,3-benzodioxolylbutanamine (Some trade or other names: MBDB) (State Control Mar. 18, 2014) | |
| 109. | Ethcathinone (Some trade or other names: ETHYLPROPION, ETH-CAT) (State Control Mar. 18, 2014) | |
| 110. | Ethylone (Some trade or other names: 3,4-methylenedioxy-N-ethylcathinone) (State Control Mar. 18, 2014) | |
| 111. | N-N-Diethyl-3,4-methylenedioxycathinone (State Control Mar. 18, 2014) | |
| 112. | 3,4-methylenedioxy-propiophenone (State Control Mar. 18, 2014) | |
| 113. | 2-Bromo-3,4-methylenedioxypropiophenone (State Control Mar. 18, 2014) | |
| 114. | 3,4-methylenedioxy-propiophenone-2-oxime (State Control Mar. 18, 2014) | |
| 115. | N-Acetyl-3,4-methylenedioxycathinone (State Control Mar. 18, 2014) | |
| 116. | N-Acetyl-N-Methyl-3,4-methylenedioxycathinone (State Control Mar. 18, 2014) | |
| 117. | N-Acetyl-N-Ethyl-3,4-methylenedioxycathinone (State Control Mar. 18, 2014) | |
| 118. | 4-Bromomethcathinone (State Control Mar. 18, 2014) | |
| 119. | 3-Bromomethcathinone (State Control Mar. 18, 2014) | |
| 120. | Eutylone (beta-keto-ethylbenzodioxolylbutanamine) (State Control Mar. 18, 2014) | |
| 121. | 4'-Methoxy-alpha-pyrrolidinopropiophenone (Some trade or other names: MOPPP) (State Control Mar. 18, 2014) | |
| 122. | 4'-Methyl-alpha-pyrrolidinohexiophenone (Some trade or other names: MPHP) (State Control Mar. 18, 2014) | |
| 123. | Benocyclidine (BCP) or Benzothiophenylcyclohexylpiperidine (Some trade or other names: BTCP) (State Control Mar. 18, 2014) | |
| 124. | 4-Fluoro-(methylamino)butyrophenone (Some trade or other names: F-MABP) (State Control Mar. 18, 2014) | |
| 125. | 3-Methyl-4-Methoxymethacathinone (Some trade or other names: 3-Me-4-MeO-MCAT) (State Control Mar. 18, 2014) | |
| 126. | 4-Methyl-(ethylamino)-butryophenone (Some trade or other names: Me-EABP) (State Control Mar. 18, 2014) | |
| 127. | 4-Ethyl-methcathinone (Some trade or other names: 4-EMC) (State Control Mar. 18, 2014) | |
| 128. | 4-methoxy-N-ethylcathinone (bk-PMC; p-methox-ethcathinone) (State Control Mar. 18, 2014) | |
| 129. | 4'-Methoxy-alpha-pyrroldino-propiophenone (MeOPPP; 4'-MeO-PPP) (State Control Mar. 18, 2014) | |
| 130. | 3-Fluorocathinone (3-FC) (State Control Mar. 18, 2014) | |
| 131. | 4-Fluorocathinone (4-FC) (State Control Mar. 18, 2014) | |
| 132. | 4-methyl-buphedrone (4-MeMABP; 4MeBP; BZ-6378) (State Control Mar. 18, 2014) | |
| 133. | 3,4-Methylenedioxy-N-benzylcathinone (Some trade or other names: BMDP) (State Control Mar. 18, 2014) | |
| 134. | N-Benzyl-butylone (Some trade or other names: BMDB) (State Control Mar. 18, 2014) | |
| 135. | N-Hydroxy-3,4-methlyenedioxymethcathinone (State Control Mar. 18, 2014) | |
| 136. | N-ethylbuphedrone (Some trade or other names: NEB) (State Control Mar. 18, 2014) | |
| 137. | 4-Fluorobuphedrone (Some trade or other names: 4-FBP) (State Control Mar. 18, 2014) | |
| 138. | 4-Methoxy-pyrrolidinbutrophenone (4-MeO-PBP) (State Control Mar. 18, 2014) | |
| 139. | 4-Ethyl-pyrrolidinobutrophenone (Some trade or other names: 4-Et-PBP) (State Control Mar. 18, 2014) | |
| 140. | 5-(2-aminopropyl)indole (Some trade or other names: 5-IT) (State Control Mar. 18, 2014) | |
| 141. | 1-phenyl-2-(piperidin-1-yl)butan-1-one State Control Mar. 18, 2014) | |
| 142. | 2,4,5-Trimethyl-methacathinone (Some trade or other names: 2,4,5-TMMC) (State Control Mar. 18, 2014) | |
| 143. | alpha-pyrrolidino-heptiophenone (Some trade or other names: alpha-PHpP) (State Control Mar. 18, 2014) | |
| 144. | 4-Methylamphetamine (4-MA: pTAP; PAL-313; 4-MeA; PmeA) (State Control Mar. 18, 2014) | |
| 145. | N-Ethyl-methamphetamine (State Control Mar. 18, 2014) | |
| 146. | 4-(2-Aminopropyl)benzofuran (Some trade or other names: 4-APB) (State Control Mar. 18, 2014) | |
| 147. | 5-(2-Aminopropyl)-2,3-dihydro-1H-indene (5-APDI; IAP; AIP; indanylaminoporpane) (State Control Mar. 18, 2014) | |
| 148. | 6,7-Methylenedioxy-2-aminotetralin (Some trade or other names: MDAT) (State Control Mar. 18, 2014) | |
| 149. | 4-Methylthioamphetamine (4-MTA; P1882) (State Control Mar. 18, 2014) | |
| 150. | 4-Chloroamphetamine (p-chloro-amphetamine) (State Control Mar. 18, 2014) | |
| 151. | 2,4,6-Trimethoxyamphetamine (Some trade or other names: TMA-6) (State Control Mar. 18, 2014) | |
| 152. | 2,4,5-Trimethoxyamphetamine (Some trade or other names: TMA-2) (State Control Mar. 18, 2014) | |
| 153. | 2,5-Dimethylamphetamine (Some trade or other names: 2,5-DMA) (State Control Mar. 18, 2014) (State Control Mar. 18, 2014) | |
| 154. | 3,4-Dimethylamphetamine (Some trade or other names: 3,4-DMA) (State Control Mar. 18, 2014) | |
| 155. | N-propylamphetamine (State Control Mar. 18, 2014) | |
| 156. | 4-Hydroxyamphetamine (State Control Mar. 18, 2014) | |
| 157. | 3-Hydroxyamphetamine (State Control Mar. 18, 2014) | |
| 158. | Methylenedioxydimethylamphetamine (Some trade or other names: MDDM) (State Control Mar. 18, 2014) | |
| 159. | 2-Aminoindane (Some trade or other names: 2-AI) (State Control Mar. 18, 2014) | |
| 160. | 5,6-Methylenedioxy-N-methyl-aminoindane (Some trade or other names: MDMAI) (State Control Mar. 18, 2014) | |
| 161. | 2C-T-21 (State Control Mar. 18, 2014) | |
| 162. | 2C-B-Fly (State Control Mar. 18, 2014) | |
| 163. | 3,4-dimethyl-2,5-dimethoxyphenethylamine (2C-G) (State Control Mar. 18, 2014) | |
| 164. | 25D-NBOMe (State Control Mar. 18, 2014) | |
| 165. | 25G-NBOMe (State Control Mar. 18, 2014) | |
| 166. | 25N-NBOMe (State Control Mar. 18, 2014) | |
| 167. | Bromo-benzyldifuranyl-isopropylamine (Some trade or other names: Bromo Dragon Fly) (State Control Mar. 18, 2014) | |
| 168. | 3C-B fly (State Control Mar. 18, 2014) | |
| 169. | 2,5-Dimethoxy-4-ethylthioamphetamine (Some trade or other names: Aleph-2) (State Control Mar. 18, 2014) | |
| 170. | 1-[(4-ethoxy-2,5-dimethoxy)phenyl]propan-2-amine (Some trade or other names: MEM) (State Control Mar. 18, 2014) | |
| 171. | 1-[2,5-dimethoxy-4-(propylthio)phenyl]propan-2-amine (Some trade or other names: Aleph-7) (State Control Mar. 18, 2014) | |
| 172. | N-benzyl-2-phenylethylanamine (State Control Mar. 18, 2014) | |
| 173. | N,N-dimethyl-2-phenylethanamine (State Control Mar. 18, 2014) | |
| 174. | 6-chloro-2-aminotetralin (Some trade or other names: 6-CAT) (State Control Mar. 18, 2014) | |
| 175. | 2-phenylpropan-1-amine (Some trade or other names: B-Me-PEA) (State Control Mar. 18, 2014) | |
| 176. | 2-Phenethylamine (Some trade or other names: 2-PEA) (State Control Mar. 18, 2014) | |
| 177. | 1-methylamino-1-(3,4-methylenedioxyphenyl)propane (Some trade or other names: M-ALPHA) (State Control Mar. 18, 2014) | |
| 178. | Camfetamine (State Control Mar. 18, 2014) | |
| 179. | Methoxyphenamine (State Control Mar. 18, 2014) | |
| 180. | 4-methylaminorex (Some trade or other names: 4-MAR; 4-MAX; U4Euh; Euphoria; Ice) (State Control Mar. 18, 2014) | |
| 181. | (1-thiophen-2-yl)propan-2-amine (Thienoamphetamine) (State Control Mar. 18, 2014) | |
| 182. | Dimethocaine (State Control Mar. 18, 2014) | |
| 183. | 4-Fluoroephedrine (State Control Mar. 18, 2014) | |
| 184. | 4-methyaminorex (p-methyl derivative) (State Control Mar. 18, 2014) | |
| 185. | 1-[(N-methylpiperidin-2-yl)methyl]-2-methyl-3-(naphthalen1-oyl)-6-nitroindole (AM1221) (State Control Mar. 18, 2014) | |
| 186. | (1-butyl-1H-indol-3-yl)(4-methoxyphenyl)-methanone (RCS-4 (C4) homolog) (State Control Mar. 18, 2014) | |
| 187. | 5-[3-(1-naphthoyl)-1H-indole-1-yl]pentanenitrile (Some trade or other names: AM2232) (State Control Mar. 18, 2014) | |
| 188. | 1-(Pentyl)-3-(4-bromo-1-naphthoyl)-indole (Some trade or other names: JWH-387) (State Control Mar. 18, 2014) | |
| 189. | 1-(Pentyl)-3-(4-fluoro-1-naphthoyl)-indole (Some trade or other names: JWH-412) (State Control Mar. 18, 2014) | |
| 190. | 1-(5-chlorpentyl)-3-(2-iodobenzoyl)indole (Some trade or other names: AM694 Derivative) (State Control Mar. 18, 2014) | |
| 191. | (2-iodo-5-nitrophenyl)-[1-[(1-methylpiperidin-2-yl]methyl]1H-indol-3-yl]-methanone (Some trade or other names: AM1241) (State Control Mar. 18, 2014) | |
| 192. | 1-Pentyl-3-[1-(4-propyl)naphthoyl]indole (Some trade or other names: JWH-182) (State Control Mar. 18, 2014) | |
| 193. | JWH-081 2-methoxynaphthyl isomer (Some trade or other names: JWH-267) (State Control Mar. 18, 2014) | |
| 194. | (3-methoxyphenyl) (l-pentyl-1H-indol-3-yl)methanone (Some trade or other names: RCS-4 3-methoxy isomer) (State Control Mar. 18, 2014) | |
| 195. | 1-(5-fluoropentyl)-1H-indol-3-yl-methanone (EAM-2201) (State Control Mar. 18, 2014) | |
| 196. | ADB-FUBINACA (State Control Mar. 18, 2014) | |
| 197. | ADBICA (State Control Mar. 18, 2014) | |
| 198. | AM-279 (State Control Mar. 18, 2014) | |
| 199. | JWH-370 (State Control Mar. 18, 2014) | |
| 200. | NNE-1 (State Control Mar. 18, 2014) | |
| 201. | MAM-2201 chloropentyl derivative (State Control Mar. 18, 2014) | |
| 202. | 1-(5-fluoropentyl)-3-(2-methyl-benzoyl)indole (State Control Mar. 18, 2014) | |
| 203. | 1-(5-fluoropentyl)-3-(2-ethylbenzoyl)indole (State Control Mar. 18, 2014) | |
| 204. | AB-005 (State Control Mar. 18, 2014) | |
| 205. | AB-005 Azepane isomer (State Control Mar. 18, 2014) | |
| 206. | 4-hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-one (4-HTMPIPO) (State Control Mar. 18, 2014) | |
| 207. | UR-12 (State Control Mar. 18, 2014) | |
| 208. | 5-Fluoro-ADBICA (State Control Mar. 18, 2014) | |
| 209. | BAY-38-7271; KN 38-7271 (State Control Mar. 18, 2014) | |
| 210. | JTE-907 (State Control Mar. 18, 2014) | |
| 211. | Org 27569 (State Control Mar. 18, 2014) | |
| 212. | Org 27759 (State Control Mar. 18, 2014) | |
| 213. | Org 29647 (State Control Mar. 18, 2014) | |
| 214. | LY 2183240 (State Control Mar. 18, 2014) | |
| 215. | JTE 7-31 (State Control Mar. 18, 2014) | |
| 216. | URB 937 (State Control Mar. 18, 2014) | |
| 217. | 3-methoxy-eticyclidine (Some trade or other names: 3-MeO-PCE) (State Control Mar. 18, 2014) | |
| 218. | 1-Phenylcyclohexanamine (Some trade or other names: PCA) (State Control Mar. 18, 2014) | |
| 219. | 4-Methyl-phencyclidine (Some trade or other names: 4-Me-PCP) (State Control Mar. 18, 2014) | |
| 220. | 4-Methoxy-eticyclidine (Some trade or other names: 4-MeO-PCE) (State Control Mar. 18, 2014) | |
| 221. | 4-Methoxyphencyclidine (Some trade or other names: Methoxydine; 4MeO-PCP) (State Control Mar. 18, 2014) | |
| 222. | 3-Methoxyphencyclidine (Some trade or other names: 3-MeO-PCP) (State Control Mar. 18, 2014) (Federal Control Apr. 22, 2026) | 7457 |
| 223. | 1-phenyl-N-propylcyclohexanamine (Some trade or other names: PCPr) (State Control Mar. 18, 2014) | |
| 224. | N-(2-methoxyethyl)-1-phenylcyclohexanamine (Some trade or other names: PCMEA) (State Control Mar. 18, 2014) | |
| 225. | N-(2-ethoxyethyl)-1-phenylcyclohexanamine (Some trade or other names: PCEEA) (State Control Mar. 18, 2014) | |
| 226. | N-(3-methoxypropyl)-1-phenylcyclohexanamine (Some trade or other names: PCMPA) (State Control Mar. 18, 2014) | |
| 227. | 3-Hydroxy-phencyclidine (Some trade or other names: 3-OH-PCP) (State Control Mar. 18, 2014) | |
| 228. | Methoxyketamine (Some trade or other names: 2-MeO-2-deschloro-ketamine) (State Control Mar. 18, 2014) | |
| 229. | Tiletamine (Some trade or other names: TCE) (State Control Mar. 18, 2014) | |
| 230. | N-ethylnorketamine (State Control Mar. 18, 2014) | |
| 231. | N-Methyltryptamine (Some trade or other names: NMT) (State Control Mar. 18, 2014) | |
| 232. | N-Methyl-N-isopropyltryptamine (Some trade or other names: MiPT; MIPT) (State Control Mar. 18, 2014) | |
| 233. | 4-hydroxy-N,N-methylisopropyltryptamine (Some trade or other names: 4-OH-MiPT) (State Control Mar. 18, 2014) | |
| 234. | 4-Acetoxy-N,N-diisopropyl-tryptamine(4-AcO-DiPT: 4-AcO-DIPT; 4-Acetoxy-MiPT) (State Control Mar. 18, 2014) | |
| 235. | 4-Methoxy-N,N-dimethyltryptamine (Some trade or other names: 4-MeO-DMT) (State Control Mar. 18, 2014) | |
| 236. | 5-Hydroxytryptamine (Some trade or other names: 5-HT) (State Control Mar. 18, 2014) | |
| 237. | 5-acetoxy-N,N-dimethyltryptamine (Some trade or other names: 5-AcO-DMT) (State Control Mar. 18, 2014) | |
| 238. | 5-Methoxy-N,N-dipropyltryptamine (Some trade or other names: 5-MeO-DPT) (State Control Mar. 18, 2014) | |
| 239. | d-Lysergic acid amide (Some trade or other names: LSA; ergine) (State Control Mar. 18, 2014) | |
| 240. | 2,5-dimethoxy-4-chloroamphetamine (Some trade or other names: DOC) (State Control Mar. 18, 2014) | |
| 241. | N-(2-Methoxybenzyl)-4-iodo-2,5-dimethoxyphenethylamine (Some trade or other names: 25I-NBOMe) (State Control Mar. 18, 2014) | |
| 242. | 4-Ethyl-2,5-dimethoxyphenethylamine (Some trade or other names: 2C-E) (State Control Mar. 18, 2014) | |
| 243. | 2,5-Dimethoxy-4-iodophenethylamine (Some trade or other names: 2C-I) (State Control Mar. 18, 2014) | |
| 244. | 6-(2-Aminopropyl)-2,3-dihydrobenzofuran (Some trade or other names: 6-APDB) (State Control Mar. 18, 2014) | |
| 245. | 6-(2-Aminopropyl)benzofuran (Some trade or other names: 6-APB) (State Control Mar. 18, 2014) | |
| 246. | 5-(2-Aminopropyl)-2,3-dihydrobenzofuran (Some trade or other names: 5-APDB) (State Control Mar. 18, 2014) | |
| 247. | 5-(2-Aminopropyl)benzofuran (Some trade or other names: 5-APB) (State Control Mar. 18, 2014) | |
| 248. | 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (Some trade or other names: 2C-T-7) (State Control Mar. 18, 2014) | |
| 249. | 2,5-Dimethoxy-4-(n)-propylphenethylamine (Some trade or other names: 2C-P) (State Control Mar. 18, 2014) | |
| 250. | 2,5-Dimethoxy-4-bromoamphetamine (Some trade or other names: DOB) (State Control Mar. 18, 2014) | |
| 251. | 2,5-Dimethoxy-4-bromobenzylpiperazine (Some trade or other names: 2C-B-BZP) (State Control Mar. 18, 2014) | |
| 252. | 2,5-Dimethoxy-4-bromophenethylamine (Some trade or other names: 2C-B) (State Control Mar. 18, 2014) | |
| 253. | 2,5-Dimethoxy-4-chlorophenethylamine (Some trade or other names: 2C-C) (State Control Mar. 18, 2014) | |
| 254. | 2,5-Dimethoxy-(4-ethylthio)phenethylamine (Some trade or other names: 2C-T-2) (State Control Mar. 18, 2014) | |
| 255. | 2,5-Dimethoxy-4-iodoamphetamine (Some trade or other names: DOI) (State Control Mar. 18, 2014) | |
| 256. | 2,5-Dimethoxy-4-methylamphetamine (Some trade or other names: DOM) (State Control Mar. 18, 2014) | |
| 257. | 2,5-Dimethoxyphenethylamine (Some trade or other names: 2C-H) (State Control Mar. 18, 2014) | |
| 258. | 2-(2,5-Dimethoxyphenyl-4-bromo)-N-(2- methoxybenzyl)ethanamine (Some trade or other names: 25B-NBOMe) (State Control Mar. 18, 2014) | |
| 259. | 2-(2,5-Dimethoxyphenyl-4-chloro)-N-(2-methoxybenzyl)ethanamine (Some trade or other names: 25C-NBOMe) (State Control Mar. 18, 2014) | |
| 260. | 2-(2,5-Dimethoxyphenyl-4-ethyl)-N-(2-methoxybenzyl)ethanamine (Some trade or other names: 25E-NBOMe) (State Control Mar. 18, 2014) | |
| 261. | 2-Ethylmethcathinone (Some trade or other names: 2-EMC) (State Control Mar. 18, 2014) | |
| 262. | 2-(2,5-Dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (Some trade or other names: 25H-NBOMe) (State Control Mar. 18, 2014) | |
| 263. | BZP (Benzylpiperazine) (State Control Mar. 18, 2014) | |
| 264. | para-Fluorophenylpiperazine (State Control Mar. 18, 2014) | |
| 265. | 1-(4-Methylphenyl)piperazine (State Control Mar. 18, 2014) | |
| 266. | meta-Cholorophenylpiperazine (State Control Mar. 18, 2014) | |
| 267. | para-Methoxyphenylpiperazine (State Control Mar. 18, 2014) | |
| 268. | DBZP (1,4-dibenzylpiperazine) (State Control Mar. 18, 2014) | |
| 269. | TFMPP (3-Trifluoromethylphenylpiperazine) (State Control Mar. 18, 2014) | |
| 270. | 2C-T-4 (2,5-Dimethoxy-4-isopropylthiophenethylamine) (State Control Mar. 18, 2014) | |
| 271. | 2C-T (2,5-Dimethoxy-4-methylthiophenethylamine) (State Control Mar. 18, 2014) | |
| 272. | 2C-D (2-(2,5-Dimethoxy-4-methylphenyl)ethanamine) (State Control Mar. 18, 2014) | |
| 273. | 2C-N 2,5-Dimethoxy-4-nitrophenethylamine (State Control Mar. 18, 2014) | |
| 274. | 5-methoxy-N,N-diallyltryptamine (Some trade or other names: 5-MeO-DALT) (State Control Mar. 18, 2014) | |
| 275. | 5-Methoxy-N,N-Diisopropyltryptamine (Some trade or other names: 5-MeO-DIPT) (State Control Mar. 18, 2014) | |
| 276. | 5-Methoxy-alpha-methyltryptamine (Some trade or other names: 5-MeO-AMT) (State Control Mar. 18, 2014) | |
| 277. | 4-Acetoxy-N,N-dimethyltryptamine (Some trade or other names: 4-AcO-DMT) (State Control Mar. 18, 2014) | |
| 278. | 4-Hydroxy-N,N-diethyltryptamine (Some trade or other names: 4-HO-DET) (State Control Mar. 18, 2014) | |
| 279. | 4-Hydroxy-N,N-diisopropyltryptamine (Some trade or other names: 4-HO-DIPT) (State Control Mar. 18, 2014) | |
| 280. | 4-Hydroxy-N-methyl-N-ethyltryptamine (Some trade or other names: 4-OH-MET) (State Control Mar. 18, 2014) | |
| 281. | 5-Methoxy-N,N-diethyltryptamine (Some trade or other names: 5-MeO-DET) (State Control Mar. 18, 2014) | |
| 282. | 5-Methoxy-N-methyl-N-isopropyltryptamine (Some trade or other names: 5-MeO-MIPT) (State Control Mar. 18, 2014) | |
| 283. | 4-Acetoxy-N,N-diethyltryptamine (Some trade or other names: 4-AcO-DET) (State Control Mar. 18, 2014) | |
| 284. | 4-Acetoxy-N-methyl-N-isopropyltryptamine (Some trade or other names: 4-AcO-MIPT) (State Control Mar. 18, 2014) | |
| 285. | N,N-Dipropyltryptamine (Some trade or other names: DPT) (State Control Mar. 18, 2014) | |
| 286. | N,N-Diisopropyltryptamine (Some trade or other names: DIPT) (State Control Mar. 18, 2014) | |
| 287. | 4-Methoxy-N-methyl-N-isopropyltryptamine (Some trade or other names: 4-MeO-MIPT) (State Control Mar. 18, 2014) | |
| 288. | Tyramine (4-Hydroxyphenethylamine) (State Control Mar. 18, 2014) | |
| 289. | 5-Hydroxy-alpha-methyltryptamine (State Control Mar. 18, 2014) | |
| 290. | 5-Hydroxy-N-methyltryptamine (State Control Mar. 18, 2014) | |
| 291. | 5-Methoxy-N,N-dimethyltryptamine (State Control Mar. 18, 2014) | |
| 292. | 5-Methyl-N,N-dimethyltryptamine (State Control Mar. 18, 2014) | |
| 293. | Diphenylprolinol (Some trade or other names: D2PM; diphenyl-2-pyrrolidinemethanol) (State Control Mar. 18, 2014) | |
| 294. | 3,4 Dichloromethylphenidate (Some trade or other names: 3,4-CTMP) (State Control Mar. 18, 2014) | |
| 295. | 3-chloromethyl-phenidate (Some trade or other names: 3-CTMP) (State Control Mar. 18, 2014) | |
| 296. | 4-Methylmethylphenidate (State Control Mar. 18, 2014) | |
| 297. | 4-Fluoromethyl-phenidate (Some trade or other names: 4-FTMP) (State Control Mar. 18, 2014) | |
| 298. | Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate (State Control Mar. 18, 2014) (Federal Control Nov. 21, 2024) | 1727 |
| 299. | Etizolam (Etilaam, Etizola, Sedekopan, Pasaden, Depas) (State Control Mar. 18, 2014) (Federal Control Apr. 1, 2026) | 2780 |
| 300. | Phenazepam (State Control Mar. 18, 2014) | |
| 301. | Pyrazolam (State Control Mar. 18, 2014) | |
| 302. | CL-218,872 (State Control Mar. 18, 2014) | |
| 303. | Zopiclone (State Control Mar. 18, 2014) | |
| 304. | Salvinorin A (State Control Mar. 18, 2014) | |
| 305. | AH-7921 (State Control Mar. 18, 2014) | |
| 306. | O-Desmethyltramadol (Some trade or other names: 0-DT; ODT) (State Control Mar. 18, 2014) | |
| 307. | Desmorphine (Dihydrodesoxymorphine; permonid; krokodil; crocodile) (State Control Mar. 18, 2014) | |
| 308. | Acetyl Fentanyl (desmethylfentanyl) (State Control Mar. 18, 2014) | |
| 309. | 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45) (State Control Mar. 18, 2014) | |
| 310. | 1-(2-methoxyphenyl)piperazine (Some trade or other names: MOPIP) (State Control Mar. 18, 2014) | |
| 311. | 1-(4-Chlorophenyl)piperazine (Some trade or other names: pCPP) (State Control Mar. 18, 2014) | |
| 312. | para-Methoxyphenyl-piperazine (Some trade or other names: MBZP) (State Control Mar. 18, 2014) | |
| 313. | Methylmethaqualone (State Control Mar. 18, 2014) | |
| 314. | Etaqualone (State Control Mar. 18, 2014) | |
| 315. | 5-Iodo-2-aminoindane (Some trade or other names: 5-IAI) (State Control Mar. 18, 2014) | |
| 316. | 5,6-(Methylenedioxy)-2-aminoindane (Some trade or other names: 5,6-MDAI) (State Control Mar. 18, 2014) | |
| 317. | 4,5-(Methylenedioxy)-2-aminoindane (Some trade or other names: 4,5-MDAI) (State Control Mar. 18, 2014) | |
| 318. | MMAI (State Control Mar. 18, 2014) | |
| 319. | W-15 (State Control Mar. 18, 2014) | |
| 320. | W-18 (State Control Mar. 18, 2014) | |
| 321. | N-[(1S)1-(aminocarbonyl)-2-methylpropyl]-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide; some trade or other names: AB-CHMINACA (State Control Feb. 1, 2016) | |
| 322. | Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate; some trade or other names: NM-2201, CBL-2201 (State Control Feb. 1, 2016) | |
| 323. | N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1Hindazole-3- carboxamide; some trade or other names: AB-PINACA (State Control Feb. 1, 2016) | |
| 324. | Mitragynine (State Control May 12, 2016) | |
| 325. | Hydroxymitragynine (State Control May 12, 2016) | |
| 326. | Butyrfentanyl (N-phenyl-N-[1-(2-phenylethyl)-4-pyridinyl]butyramide) (State Control April 6, 2018) | |
| 327. | Beta-Hydroxythiofentanyl (N-phenyl-N-{1-[2-hydroxy-2-(2- thienyl)ethyl)-4-piperdinyl}-propanamide) (State Control April 6, 2018) | |
| 328. | 4-methylphenethyl acetyl fentanyl (N-phenyl-N-{1-[2-(4- methylphenyl)ethyl]-4-piperdinyl}-acetamide) (State Control April 6, 2018) | |
| 329. | Acrylfentanyl (N-phenyl-N-[1-(2-phenylethyl)-4-piperdinyl]-prop-2-enamide) (State Control April 6, 2018) | |
| 330. | 3-Allylfentanyl (N-phenyl-N-[1-(2-phenylethyl)-(3s,4R)-3-prop-2enyl-4-piperidmyl]-propanamide) (State Control April 6, 2018) | |
| 331. | Benzodioxole fentanyl (N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-benzo[d] [1,3]dioxole-5-carboxamide) (State Control April 6, 2018) | |
| 332. | Benzyl carfentanil (N-phenyl-N-(1-benzyl-4-methylcarboxylate-4-piperidinyl)-propanamide) (State Control April 6, 2018) | |
| 333. | Brifentanil (N-(2-fluorophenyl)-N-{(3R,4S)-1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-3-methyl-4-piperdinyl}-2-methoxyacetamide) (State Control April 6, 2018) | |
| 334. | Cyclopentylfentanyl (N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl)-cyclopentanecarboxamide) (State Control April 6, 2018) | |
| 335. | 2,5-Dimethylfentanyl (N-phenyl-N-[1-(2-phenylethyl)-2,5-dimethyl-4-piperidinyl]-propranamide) (State Control April 6, 2018) | |
| 336. | 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-[1-(2- phenylethyl)-4-piperidinyl)-isobutyramide) (State Control April 6, 2018) | |
| 337. | Furanyl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide) (State Control April 6, 2018) | |
| 338. | Furanylethyl fentanyl (N-phenyl-N-[1-(2-furanylethyl)-4-piperidinyl]-propanamide) (State Control April 6, 2018) | |
| 339. | Isobutyryl fentanyl (N-phenyl-N-[1-(2-phenylethyl)-4-piperdinyl]-2-methylpropanamide) (State Control April 6, 2018) | |
| 340. | Lofentanil (N-phenyl-N-[1-(2-phenylethyl)-(3R,4S)-3-methyl-4-methylcarboxylate-4-piperidinyl]-propanamide) (State Control April 6, 2018) | |
| 341. | 4-Methoxybutyrfentanyl (N-(4-methoxyphenyl)-N-[1-(2-phenylethyl)- 4-piperidinyl]-butyramide) (State Control April 6, 2018) | |
| 342. | 4-Methoxymethylfentanyl (N-phenyl-N-[1-(2-phenylethyl)-4- methoxymethyl-4-piperidinyl]-propanamide) (State Control April 6, 2018) | |
| 343. | Meta-fluorobutyryl fentanyl (N-(3-fluorophenyl)-N-[1-(2- phenylethyl)-4-piperidnyl)-butyramide) (State Control April 6, 2018) | |
| 344. | Meta-fluorofentanyl (N-(3-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidnyl)-propanamide) (State Control April 6, 2018) | |
| 345. | 3-Methylbutyrfentanyl (N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-butyramide) (State Control April 6, 2018) | |
| 346. | N-Methylcarfentanyl (N-phenyl-N-(1-methyl-4-methylcarboxylate-4-piperidinyl)-propanamide) (State Control April 6, 2018) | |
| 347. | Methoxyacetylfentanyl (N-phenyl-N-[1-(2-phenylethyl)-4- piperidinyl]-2-methoxyacetamide) (State Control April 6, 2018) | |
| 348. | Mirfentanyl (N-(2-pyrazinyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-2-furamide) (State Control April 6, 2018) | |
| 349. | Ocfentanil (N-(2-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperdinyl]-2-methoxyacetamide) (State Control April 6, 2018) | |
| 350. | Ohmefentanyl (N-phenyl-N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidinyl]-propanamide) (State Control April 6, 2018) | |
| 351. | Ortho-fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-[1-(2- phenylethyl)-4-piperidnyl)-butyramide) (State Control April 6, 2018) | |
| 352. | Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidnyl)-propanamide) (State Control April 6, 2018) | |
| 353. | Para-chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-[1-(2- phenylethyl)-4-piperidinyl]-isobutyramide) (State Control April 6, 2018) | |
| 354. | 4-Fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-butyramide) (State Control April 6, 2018) | |
| 355. | Para-methoxyfentanyl (N-(4-methoxyphenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propanamide) (State Control April 6, 2018) | |
| 356. | Para-methylfentanyl (N-(4-methylphenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propanamide) (State Control April 6, 2018) | |
| 357. | 4-Phenyl fentanyl (N-phenyl-N-[4-phenyl-1-(2-phenylethyl)-4-piperidinyl]-propanamide) (State Control April 6, 2018) | |
| 358. | Trefentanyl (N-(2-fluorophenyl)-N-{1-[2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-phenyl-4-piperdinyl}-propanamide) (State Control April 6, 2018) | |
| 359. | Valeryl fentanyl (N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-pentanamide) (State Control April 6, 2018) | |
| 360. | Alpha-Methylacetylfentanyl (N-phenyl-N-[1-phenylpropan-2-yl)-4-piperidinyl]-acetamide) (State Control April 6, 2018) | |
| 361. | Alpha-Methylbutyrfentanyl (N-phenyl-N-[1-phenylpropan-2- yl)-4-piperidinyl]-butyramide) (State Control April 6, 2018) | |
| 362. | Alpha-Methylthiofentanyl (N-phenyl-N-[1-(l-thienyl-2-ylpropan-2-yl)-4-piperidinyl]-propanamide) (State Control April 6, 2018) | |
| 363. | Beta-Hydroxy fentanyl (N-phenyl-N-[1-(2-hydroxy-2-phenylethyl)-4-piperidinyl]-propanamide) (State Control April 6, 2018) | |
| 364. | Beta-Methyl fentanyl (N-phenyl-N-[1-(2-phenylpropyl)-4-piperdinyl]-propanamide) (State Control April 6, 2018) | |
| 365. | U-47700 (3,4-Dichloro-N-[(1R,2R)-2-(dimethylamino) cyclohexyl]-N-methylbenzamide) (State Control April 6, 2018) | |
| 366. | W-19 ((Z)-N-{1-[2-(4-aminophenyl)ethyl]piperidin-2-ylidene}-4-chlorobenzenesulfonamide) (State Control April 6, 2018) | |
| 367. | Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo [4,3-a][1,4]benzodiazepine) (State Control April 6, 2018) (Federal Control Apr. 1, 2026) | 2788 |
| 368. | 7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one (Flubromazepam) (Some trade or other name: 7-Bromo-5-(2-flurophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one) (State Control: Filed July 20, 2023; Effective Sept. 14, 2023) | |
| 369. | 8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo- [4,3-a][1,4]benzodiazepine (Bromazolam) (Some trade or other names: 8-Bromo-1-methyl-6-phenyl-4H-triazolo[4,3-a][1,4]benzodiazepine and DE(chloro)-bromo-alprazolam) (State Control: Filed July 20, 2023; Effective Sept. 14, 2023) | |
| 370. | 5-methoxy-N,N-dibutyltryptamine (Some other names: 5-methoxy-N,N-dibutyltryptamine (5-MeO-DBT); 5-MeO BET; N,N-dibutyl-5-methoxytryptamine; N,N-dibutyl-5-methoxy-1N-indole-3-ethanamine; and N-butyl-N-[2-(5-methoxy-1H-indole-3-yl)ethyl]butan-1-amine) (State Control; Filed Dec. 15, 2022; Effective Feb. 13, 2023) | |
| 371. | Amineptine (7-[10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-amino]-heptanoic acid) (Federal Control Dec. 19, 2022; State Jan. 18, 2023 | 1219 |
| 372. | Mesocarb (N-phenyl-N’-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate) (Federal Control Dec 22, 2022; State Jan. 21, 2023) | 1227 |
| 373. | 1-(cyclohexylmethyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide (ACHMINACA) (Some trade or other names: N-(1-adamantyl)-1-(cyclohexylmethyl)-indazole-3-carboxamide, Adamantyl-CHMINACA, and SGT-37) (State Control: Filed May 16, 2024; Effective July 15, 2024) | |
| 374. | 2-ethyl-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]-diazepine (Deschloroetizolam) (Some trade or other name: Etizolam-2) (State Control: Filed May 16, 2024; Effective July 15, 2024) |
(g) A synthetic controlled substance analogue, being a material, mixture, or preparation that contains any chemical structure of which is chemically similar to the chemical structure of any other controlled substance in Schedule I or Schedule II or that satisfies any one of the following:
| 1. | Has a stimulant, depressant, or hallucinogenic effect on the central nervous system that mimics or is similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or Schedule II. |
|---|---|
| 2. | With respect to a particular person, if the person represents or intends that the substance have a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or Schedule II and the substance is actually capable of producing a stimulant, depressant, or hallucinogenic effect on the central nervous system that mimics, is similar to, or is greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or Schedule II. |
| 3. | Has been demonstrated to have binding activity at one or more cannabinoid receptors. |
| 4. | Is capable of exhibiting cannabinoid-like activity. |
| 5. | Any compound structurally analogous to, mimicking, or derived from 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1- naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, alkyl halide, aryl halide, alkyl aryl halide, alkenyl, aliphatic alcohol, cycloalkylmethyl, cycloalkylethyl, (N- alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl, or 2-(4- morpholinyl)ethyl whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent. |
| 6. | Any compound structurally analogous to, mimicking, or derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, alkyl halide, aryl halide, alkyl aryl halide, alkenyl, aliphatic alcohol, cycloalkylmethyl, cycloalkylethyl, (N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl, or 2-(4-morpholinyl)ethyl, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent. |
| 7. | Any compound structurally analogous to, mimicking, or derived from 1-(1- naphthylmethyl)indene by substitution at the 3-position of the indene ring by alkyl, alkyl halide, aryl halide, alkyl aryl halide, alkenyl, aliphatic alcohol, cycloalkylmethyl, cycloalkylethyl, (N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl, or 2-(4-morpholinyl)ethyl whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent. |
| 8. | Any compound structurally analogous to, mimicking, or derived from 3- phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, alkyl halide, aryl halide, alkyl aryl halide, alkenyl, aliphatic alcohol, cycloalkylmethyl, cycloalky lethyl, (N-alkylpiperidin-2-y1)methyl, (tetrahydropyran-4-yl)methyl, or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent. |
| 9. | Any compound structurally analogous to, mimicking, or derived from 2-(3- hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, alkyl halide, aryl halide, alkyl aryl halide, alkenyl, aliphatic alcohol, cycloalkylmethyl, cycloalkylethyl, (N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl, or 2-(4-morpholinyl)ethyl, whether or not substituted in the cyclohexyl ring to any extent. |
| 10. | Any compound structurally analogous to, mimicking, or derived from 3-(2,2,3,3- tetramethylcyclopropoyl)indole or 1H-indol-3-yl-(2,2,3,3- tetramethylcyclopropoyl) methane by substitution at the nitrogen atom of the indole ring by alkyl, alkyl halide, aryl halide, alkyl aryl halide, alkenyl, aliphatic alcohol, cycloalkylmethyl, cycloalkylethyl, (N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl, or 2-(4- morpholinyl)ethyl whether or not further substituted in the indole ring to any extent. |
| 11. | Any compound structurally analogous to, mimicking, or derived from 3- (adamant-1-oyl)indole or 1H-indol-3-yl- (1-adamantyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, alkyl halide, aryl halide, alkyl aryl halide, alkenyl, aliphatic alcohol, cycloalkylmethyl, cycloalkylethyl, (N- alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl, or 2-(4- morpholinyl)ethyl whether or not further substituted in the indole ring to any extent. |
| 12. | Any compound structurally analogous to, mimicking, or derived from N-(1- naphthalenyl)indole-3-carboxyamide or 1H-indol-(N-naphthyl)-3-carboxamide by substitution at the nitrogen atom of the indole ring by alkyl, alkyl halide, aryl halide, alkyl aryl halide, alkenyl, aliphatic alcohol, cycloalkylmethyl, cycloalkylethyl, (N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl, or 2-(4-morpholinyl)ethyl whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent. |
| 13. | Any compound structurally analogous to, mimicking, or derived from N-(adamantan-1yl)indole-3-carboxyamide or 1H-indol-3-carboxamide-(1- adamantyl) by substitution at the nitrogen atom of the indole ring by alkyl, alkyl halide, aryl halide, alkyl aryl halide, alkenyl, aliphatic alcohol, cycloalkylmethyl, cycloalkylethyl, (N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl, or 2-(4-morpholinyl)ethyl whether or not further substituted in the indole ring to any extent. |
| 14. | Any compound structurally analogous to, mimicking, or derived from N- (adamantan-1yl)indazole-3-carboxyamide or 1H-indazole-3-carboxamide-(1- adamantyl) by substitution at the nitrogen atom of the indazole ring by alkyl, alkyl halide, aryl halide, alkyl aryl halide, alkenyl, aliphatic alcohol, cycloalkylmethyl, cycloalkylethyl, (N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl, or 2-(4-morpholinyl)ethyl whether or not further substituted in the indazole ring to any extent. |
| 15. | Any compound structurally analogous to, mimicking, or derived from N-[(1S)-1- (aminocarbonyl)-2- methylpropoyl]indazole-3-carboxyamide or 1H-indazole-3- carboxamide-N-[(1S)-1-(aminocarbonyl)-2-methylpropoyl] by substitution at the nitrogen atom of the indazole ring by alkyl, alkyl halide, aryl halide, alkyl aryl halide, alkenyl, aliphatic alcohol, cycloalkylmethyl, cycloalkylethyl, (N- alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl, or 2-(4- morpholinyl)ethyl whether or not further substituted in the indazole ring to any extent. |
| 16. | Any compound structurally analogous to, mimicking, or derived from 3-(1-naphthoyl)indazole or 1H-indazole-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indazole ring by alkyl, alkyl halide, aryl halide, alkyl aryl halide, alkenyl, aliphatic alcohol, cycloalkylmethyl, cycloalkylethyl, (N- alkylpiperidin-2- yl)methyl, (tetrahydropyran-4-yl)methyl, or 2-(4- morpholinyl)ethyl whether or not further substituted in the indazole ring to any extent, whether or not substituted in the naphthyl ring to any extent. |
| 17. | Any compound structurally analogous to, mimicking, or derived from 3-(carboxylic acid 8-quinolinyl ester)indole or 1H-indol-3-carboxylic acid-(8- quinolinyl)ester by substitution at the nitrogen atom of the indole ring by alkyl, alkyl halide, aryl halide, alkyl aryl halide, alkenyl, aliphatic alcohol, cycloalkylmethyl, cycloalkylethyl, (N-alkylpiperidin-2-yl)methyl, (tetrahydropyran-4-yl)methyl, or 2-(4-morpholinyl)ethyl whether or not further substituted in the indole ring to any extent, whether or not substituted in the quinoline ring to any extent. |
| 18. | Any compound structurally related to 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine by substitution of the iodo moiety (4 position) with other halides, alkyl, alkyl halides, thioalkyl, cycloalkyl, cycloalkylhalides and/or substitution at the nitrogen atom of the ethanamine with alkyl, alkyl halide, alkenyl, cycloalkylmethyl, cycloalkylethyl, phenyl, benzyl whether or not further substituted in the (either) phenyl ring to any extent. |
| 19. | Any compound structurally related to 2,5-dimethoxy-4-chloroamphetamine by substitution of the chloro moiety (4 position) with other halides, alkyl, alkyl halides, thioalkyl, cycloalkyl, cycloalkylhalides and/or substitution at the nitrogen atom with alkyl, alkyl halide, alkenyl, cycloalkylmethyl, cycloalkylethyl, phenyl, benzyl whether or not further substituted in the (either) phenyl ring to any extent. |
| 20. | Any compound structurally related to 2-amino-1-phenyl-1-propanone (cathinone) by substitution of the amine with alkyl, alkyl halide, alkenyl, cycloalkylmethyl, cycloalkylethyl, phenyl, benzyl whether or not further substituted in the (either) pheny1 ring to any extent. |
| 21. | Any compound structurally related to a-pyrrolidinopentiophenone (a-pvp) whether or not further substituted in the phenyl ring to any extent, whether or not further substituted in the pyrrolidine ring to any extent. |
(h) A synthetic controlled substance or analogue in subdivision (g) or this subdivision does not include any of the following:
| 1. | Any substance for which there is an approved new drug application under the Federal Food, Drug, and Cosmetic Act. |
|---|---|
| 2. | With respect to a particular person, any substance, if an exemption is in effect for investigational use, for that person, as provided by 21 U.S.C. § 355, and the person is registered as a controlled substance researcher as required under section 152.12, subdivision 3, to the extent conduct with respect to the substance is pursuant to the exemption and registration. |
(i) A controlled substance analogue is treated as a controlled substance in Schedule I.
(j) After the Alabama Department of Forensic Sciences has determined a substance to be a synthetic controlled substance analogue under this section, the department shall notify the Alabama Department of Public Health with information relevant to scheduling as provided by Section 20-2-20.
(k) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
| 1. | Clonazolam (Other name: 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) | 2786 |
|---|---|---|
| 2. | Diclazepam (Other name: 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one) | 2789 |
| 3. | (3) Etizolam (Other name: 4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine) (State Control Mar. 18, 2014; Federal Control Apr. 1, 2026) | 2780 |
| 4. | Flualprazolam (Other name: 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) | 2785 |
| 5. | Flubromazolam (Other name: 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) (State Control April 6, 2018; Federal Control Apr. 1, 2026) | 2788 |
| 6. | Gamma-Hydroxybutyric Acid (Some other names: GHB; gamma-hydroxybutyrate; 4- hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate) (State Control Oct. 23, 1998; Federal Mar. 13, 2000) | 2010 |
| 7. | Mecloqualone (Federal Control July 10, 1975; State Aug. 9, 1975) | 2572 |
| 8. | Methaqualone (Transferred Federally from Schedule II to Schedule I Aug.27, 1984) | 2565 |
(l) Stimulants. Unless specifically accepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers.
| 1. | Aminorex (Some other names: aminoxaphen, 2-amino-5-phenyl-2-oxazoline, or 4,5 dihydro-5-phenyl-2-oxazolamine (Federal Control Sept. 21, 1992; State Oct. 21, 1992) | 1585 |
|---|---|---|
| 2. | N-benzylpiperazine (Some other names: BZP: 1-benzylpiperazine), its optical isomers, salts and salts of isomers) (Federal Control Sept. 20, 2002; State Oct. 20, 2002) | 7493 |
| 3. | Cathinone (Some trade or other names: 2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone, 2-aminopropiophenone, norephedrone, and methylenedioxypyrovalerone [MDPV]) (Federal Control Feb. 16, 1993; State Mar. 18, 1993; State Emergency Order Filed Feb. 22, 2011; Effective Feb. 22, 2011; Final Adoption Filed May 26, 2011; Effective June 30, 2011) | 1235 |
| 4. | Fenethylline (Federal Control Aug. 20, 1981; State Sept. 19, 1981) | 1503 |
| 5. | Methcathinone (Some other names: 2-(methylamino)-propiophenone; alpha- (methylamino) propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; and mephedrone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers) (Federal Control May 1, 1992; State May 31, 1992; State Emergency Order Filed Feb. 22, 2011; Effective Feb. 22, 2011; Final Adoption Filed May 26, 2011; Effective June 30, 2011) | 1237 |
| 6. | 4-methylaminorex (Federal Control April 13, 1989; State May 13, 1989) | 1590 |
| 7. | N-ethylamphetamine (Federal Control Jan. 7, 1982; State Feb. 6, 1982) | 1475 |
| 8. | N,N-dimethylamphetamine (Also known as N,N,alpha-trimethylbenzenee-thanamine; and N,N,alpha-trimethylphenethylamine) (Federal Control Aug. 3, 1988; State Sept. 2, 1988) | 1480 |
| 9. | 4-Fluoroamphetamine(4-FA,1-(4-fluorophenyl)propan-2-amine,para-fluoroamphetamine) (Federal Control Feb, 17, 2026; State Control Mar. 18, 2014) | 1476 |
(m) Cannabimimetic agents. Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of cannabimimetic agents, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
| 1. | Cannibamimetic Agents | 7000 |
|---|---|---|
| (i) In this paragraph (g), cannabimimetic agent means any substance that is a cannabinoid receptor type 1 (CB1 receptor) agonist as demonstrated by binding studies and functional assays within any of the following structural classes: | ||
| (A) 2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent. | ||
| (B) 3-(1-naphthoyl)indole or 3-(1-naphthylmethane)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent. | ||
| (C) 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any extent. | ||
| (D) 1-(1-naphthylmethylene)indene by substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent. | ||
| (E) 3-phenylacetylindole or 3-benzoylindole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent. | ||
| (ii) The definition of cannabimimetic agent in this paragraph (g) includes, but is not limited to, the following substances: | ||
| (A) 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol(CP–47,497); (Federal Control Mar. 1, 2011; State Mar. 31, 2011) (Transferred Federally from Schedule I(h) to Schedule I(g) Jan. 4, 2013; State Feb. 4, 2013) (Federally Amended Drug Code Number, Feb. 19, 2026) | ||
| (B) 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol(cannabicyclohexanol or CP–47,497 C8-homolog); (Federal Control Mar. 1, 2011; State Mar. 31, 2011) (Transferred Federally from Schedule I(h) to Schedule I(g) Jan. 4, 2013; State Feb. 4, 2013) (Federally Amended Drug Code Number, Feb. 19, 2026) | ||
| (C) 1-butyl-3-(1-naphthoyl)indole(JWH–073); (Federal Control Mar. 1, 2011; State Mar. 31, 2011) (Transferred Federally from Schedule I(h) to Schedule I(g) Jan. 4, 2013; State Feb. 4, 2013) (Federally Amended Drug Code Number, Feb. 19, 2026) | ||
| (D) 1-hexyl-3-(1-naphthoyl)indole(JWH–019); (Transferred Federally from Schedule I(h) to Schedule I(g) Jan. 4, 2013; State Feb. 4, 2013) (Federally Amended Drug Code Number, Feb. 19, 2026) | ||
| (E) 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH–200); (Federal Control Mar. 1, 2011; State Mar. 31, 2011) (Transferred Federally from Schedule I(h) to Schedule I(g) Jan. 4, 2013; State Feb. 4, 2013) (Federally Amended Drug Code Number, Feb. 19, 2026) | ||
| (F) 1-pentyl-3-(2-methoxyphenylacetyl)indole(JWH–250); (Transferred Federally from Schedule I(h) to Schedule I(g) Jan. 4, 2013; State Feb. 4, 2013) (Federally Amended Drug Code Number, Feb. 19, 2026) | ||
| (G) 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole(JWH–081); (Transferred Federally from Schedule I(h) to Schedule I(g) Jan. 4, 2013; State Feb. 4, 2013) (Federally Amended Drug Code Number, Feb. 19, 2026) | ||
| (H) 1-pentyl-3-(4-methyl-1-naphthoyl)indole(JWH–122); (Transferred Federally from Schedule I(h) to Schedule I(g) Jan. 4, 2013; State Feb. 4, 2013) (Federally Amended Drug Code Number, Feb. 19, 2026) | ||
| (I) 1-pentyl-3-(4-chloro-1-naphthoyl)indole(JWH–398); (Transferred Federally from Schedule I(h) to Schedule I(g) Jan. 4, 2013; State Feb. 4, 2013) (Federally Amended Drug Code Number, Feb. 19, 2026) | ||
| (J) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole(AM694); (Transferred Federally from Schedule I(h) to Schedule I(g) Jan. 4, 2013; State Feb. 4, 2013) (Federally Amended Drug Code Number, Feb. 19, 2026) | ||
| (K) 1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR–19 and RCS–4); (Transferred Federally from Schedule I(h) to Schedule I(g) Jan. 4, 2013; State Feb. 4, 2013) (Federally Amended Drug Code Number, Feb. 19, 2026) | ||
| (L) 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR–18 and RCS–8); (Transferred Federally from Schedule I(h) to Schedule I(g) Jan. 4, 2013; State Feb. 4, 2013) (Federally Amended Drug Code Number, Feb. 19, 2026) | ||
| (M) 1-pentyl-3-(2-chlorophenylacetyl)indole(JWH–203); (Transferred Federally from Schedule I(h) to Schedule I(g) Jan. 4, 2013; State Feb. 4, 2013) (Federally Amended Drug Code Number, Feb. 19, 2026) | ||
| (N) (1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone (AM–1220); | ||
| (O) (2-iodophenyl)(1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)methanone(AM–2233); | ||
| (P) (4-ethylnaphthalen-1-yl)(1-(5-fluoropentyl)-1H-indol-3-yl)methanone(EAM–2201); | ||
| (Q) (4-methoxynaphthalen-1-yl)(2-methyl-1-pentyl-1H-indol-3-yl)methanone(JWH–098); | ||
| (R) 3-((4-methylnaphthalen-1-yl)methyl)-1-pentyl-1H-indole(JWH–184); | ||
| (S) (4-methylnaphthalen-1-yl)(1-(2-morpholinoethyl)-1H-indol-3-yl)methanone(JWH–193); | ||
| (T) (4-ethylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone(JWH–210); | ||
| (U) (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone(MAM–2201); | ||
| (V) (2-methyl-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone(JWH–007); | ||
| (W) naphthalen-1-yl(1-(pent-4-en-1-yl)-1H-indol-3-yl)methanone(JWH–022); | ||
| (X) (1-hexyl-5-phenyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone(JWH–147); | ||
| (Y) 2-(3-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one(JWH–302); | ||
| (Z) (5-(2-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone(JWH–307); | ||
| (AA) (4-fluoronaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone(JWH–412); | ||
| (BB) (5-methyl-3-(morpholinomethyl)-2,3-dihydro-[1,4]oxazino[2,3,4-hi]indol-6-yl)(naphthalen-1-yl)methanone(WIN 55,212–2); | ||
| (CC) 2-(5-hydroxy-2-(3-hydroxypropyl)cyclohexyl)-5-(2-methyloctan-2-yl)phenol(CP–55,940); | ||
| (DD) 2-(3-hydroxycyclohexyl)-5-(2-methylheptan-2-yl)phenol(CP–47,497 C6 homolog); and | ||
| (EE) 2-(3-hydroxycyclohexyl)-5-(2-methyldecan-2-yl)phenol(CP–47,497 C9 homolog). |
(n) Temporary listing of substances subject to emergency scheduling. Any material, compound, mixture, or preparation which contains any quantity of the following substances:
| 1. | (6aS,10aS)-9-(Hydroxymethyl0-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10a tetrahydrbenzo[c]chromen-1-o1) (Other names: HU-211) | |
|---|---|---|
| 2. | 1-Pentyl-2-methyl-3-(1-naphthoyl)indole (Other names: JWH-007) | |
| 3. | (2-Methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone (Other names: JWH-015) | |
| 4. | 1-Hexyl-3-(naphthalene-1-oyl)indole (Other names: JWH-200) | |
| 5. | (1-(2-Morpholin-4-ylethuyl)indole-3-yl)-naphthalene-1-ylmethanone (other names:JWH-200) | |
| 6. | 2-(2-Methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone (Other names: JWH-250) | |
| 7. | 1-Pentyl-3-(4-Chloro-1-naphthoyl)indole (Other names: JWH-398) | |
| 8. | 2-[(1R, 3S)-3-hydroxycclohexyl]-5-(2-methylnonan-2-yl)phenol (Other names: CP 47, 497) | |
| 9. | N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: acetyl fentanyl) (Federal Control July 17, 2015; State Aug. 16, 2015) | 9821 |
| 10. | N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide, its isomers, esters, ethers, salts and salts of isomers, esters and ethers (Other name: Furanyl fentanyl) (Federal Control Nov. 29, 2016; State Dec. 28, 2016) | 9834 |
| 11. | N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide its isomers, esters, ethers, salts and salts of isomers, esters, and ethers. (Other names: acryl fentanyl, acryloylfentanyl) (Federal Control July 14, 2017; State Aug. 13, 2017) | 9811 |
Schedule II
(a) Schedule II shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Controlled Substances Code Number set forth opposite it.
(b) Substances, vegetable origin or chemical synthesis. Unless specifically excepted or unless listed in another schedule, any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis.
- Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, naldemedine, nalmefene, naloxegol, naloxone, 6β - naltrexol, naltrexone, and samidorphan, and their respective salts, but including the following:
| (i) | Codeine | 9050 |
|---|---|---|
| (ii) | Dihydroetorphine (Federal Control Nov. 17, 2000; State Dec. 17, 2000) | 9334 |
| (iii) | Ethylmorphine | 9190 |
| (iv) | Etorphine hydrochloride | 9059 |
| (v) | Granulated opium | 9640 |
| (vi) | Hydrocodone | 9193 |
| (vii) | Hydromorphone | 9150 |
| (viii) | Metopon | 9260 |
| (ix) | Morphine | 9300 |
| (x) | Noroxymorphone (Federal Control Aug. 16, 2019; State Sept. 15, 2019) | 9668 |
| (xi) | Opium extracts | 9610 |
| (xii) | Opium fluid | 9620 |
| (xiii) | Oripavine (Federal Control Sept. 24, 2007; State Oct. 24, 2007) | 9330 |
| (xiv) | Oxycodone | 9143 |
| (xv) | Oxymorphone | 9652 |
| (xvi) | Powdered opium | 9639 |
| (xvii) | Raw opium | 9600 |
| (xviii) | Thebaine | 9333 |
| (xix) | Tincture of opium | 9630 |
-
Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (b)(1) of this section except that these substances shall not include the isoquinoline alkaloids of opium.
-
Opium poppy and poppy straw.
-
Coca leaves (9040) and any salt, compound, derivative, or preparation of coca leaves (including cocaine (9041) and ecgonine (9180) and their salts, isomers, derivatives and salts of isomers, and derivatives), and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substitutes shall not include:
| (i) | Decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine; or (Federal Control Sept. 11, 2015; State Oct. 11, 2015) |
|---|---|
| (ii) | [123I]ioflupane (Federal Control Sept. 11, 2015; State Oct. 11, 2015) |
| (iii) | [18F]FP—CIT (Federal Control Nov. 21, 2022; State Jan. 20, 2023) |
- Concentrate of poppy straw (the crude extract of Poppy straw in either liquid, solid or powder form which contains the phenanthrine alkaloids of the opium poppy)--- 9670
(c) Opiates. Unless specifically excepted or unless in another schedule any of the following opiates, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan excepted:
| 1. | Alfentanil (Transferred Federally from Schedule I to Schedule II Jan. 23, 1987; State Feb. 22, 1987) | 9737 |
|---|---|---|
| 2. | Alphaprodine | 9010 |
| 3. | Anileridine | 9020 |
| 4. | Bezitramide | 9800 |
| 5. | Bulk Dextropropoxyphene (non-dosage forms) (Federal Control Sept. 22, 1980; State Oct. 22, 1980) | 9273 |
| 6. | Carfentanil (Federal Control Oct. 28, 1988; State Nov. 27, 1988) | 9743 |
| 7. | Dihyrocodeine | 9120 |
| 8. | Diphenoxylate | 9170 |
| 9. | Fentanyl | 9801 |
| 10. | Isomethadone | 9226 |
| 11. | Levo-alphacetylmethadol (Federal transfer effective Aug. 18, 1993; State Sept. 17, 1993) | 9648 |
| 12. | Levomethorphan | 9210 |
| 13. | Levorphanol | 9220 |
| 14. | Metazocine | 9240 |
| 15. | Methadone | 9250 |
| 16. | Methadone-Intermediate, 4-cyano-2-dimethyl-amino-4, 4- diphenyl Butane | 9254 |
| 17. | Moramide-Intermediate, 2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid | 9802 |
| 18. | N-3-methoxythiophen-2-yl)methylamine (Other name: Oliceridine) (Federal Control July 12, 2021; State Control August 11, 2021) | 9245 |
| 19. | Pethidine (meperidine) | 9230 |
| 20. | Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine | 9232 |
| 21. | Pethidine-Intermediate-B, ethyl-4-phenyl-piperidine-4-carboxylate | 9233 |
| 22. | Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid | 9234 |
| 23. | Phenazocine | 9715 |
| 24. | Piminodine | 9730 |
| 25. | Racemethorphan | 9732 |
| 26. | Racemorphan | 9733 |
| 27. | Remifentanil (Federal Control November 5, 1996; State December 5, 1996) | 9739 |
| 28. | Sufentanil (Transferred Federally from Schedule I to Schedule II May 25, 1984; State June 24, 1984) | 9740 |
| 29. | Tapentadol (Federal Control June 22, 2009; State July 22, 2009) | 9780 |
| 30. | Thiafentanil (Federal Control June 18, 2019; State Control July 18, 2019) | 9729 |
(d) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:
| 1. | Amphetamine, its salts, optical isomers, and salts of its optical isomers (Transferred Federally from Schedule III to Schedule II on July 17, 1971; State effective upon adoption of the Alabama Uniform Controlled Substances Act on Sept. 16, 1971) | 1100 |
|---|---|---|
| 2. | Methamphetamine, its salts, isomers, and salts of its isomers (Transferred Federally from Schedule III to II on July 17, 1971; State effective upon adoption of the Alabama Uniform Controlled Substances Act on Sept. 16, 1971) | 1105 |
| 3. | Phenmetrazine and its salts (Transferred Federally from Schedule III to II on July 17, 1971; State effective upon adoption of the Alabama Uniform Controlled Substances Act on Sept. 16, 1971) | 1631 |
| 4. | Methylphenidate (Transferred Federally from Schedule III to II on July 17, 1971; State effective upon adoption of the Alabama Uniform Controlled Substances Act on Sept. 16, 1971) | 1724 |
| 5. | Lisdexamfetamine, its salts, isomers, and salts of its isomers (Federal Control June 4, 2007; State July 4, 2007) | 1205 |
(e) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
| 1. | Amobarbital (Rescheduled Federally Dec. 17, 1973; State Jan. 16, 1974) | 2125 |
|---|---|---|
| 2. | Glutethimide (Rescheduled Federally Mar. 21, 1991; State April 20, 1991) | 2550 |
| 3. | Pentobarbital (Rescheduled Federally Dec. 17, 1973; State Jan. 16, 1974) | 2270 |
| 4. | Phencyclidine (Rescheduled Federally Feb. 24, 1978; State Mar. 26, 1978) | 7471 |
| 5. | Phenibut (State Control Nov. 14 2021) | |
| 6. | Secobarbital (Rescheduled Federally Dec. 17, 1973; State Jan. 16, 1974) | 2315 |
(f) Hallucinogenic substances.
| 1. | Nabilone (Another name for nabilone: [+/-]-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6-6,- dimethyl-9H-dibenzo[b,d] pyran-9-one) (Federal Control April 7, 1987; State Control May 7, 1987) | 7379 |
|---|---|---|
| 2. | Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration (Federal Control Nov. 22, 2017; State Control Dec. 22, 2017) | 7365 |
(g) Immediate precursors. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:
| 1. | Immediate precursor to amphetamine and methamphetamine: | |
|---|---|---|
| (i) | Phenylacetone (Some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone) (Federal Control Feb. 11, 1980; State Mar. 12, 1980) | 8501 |
| 2. | Immediate precursors to phenylcyclidine (PCP) (Federal Control June 16, 1978; State July 16, 1978) | |
| (i) | 1-phenylcyclohexylamine | 7460 |
| (ii) | 1-piperidinocyclohexanecarbonitrile (PCC) | 8603 |
| 3. | Immediate precursor to fentanyl: | |
| (i) | 4-anilino-N-phenethylpiperidine (ANPP) (Federal Control Feb. 7, 2019; State Mar. 9, 2019) | 8333 |
| (ii) | N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl) (Federal Control May 18, 2020; State June 17, 2020. | 8366 |
(h) Any drug product exempted from control by the Federal Drug Enforcement Administration will also be exempted from the Alabama Controlled Substances List unless the State Committee of Public Health takes additional action.
Schedule III
(a) Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.
(b) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
| 1. | Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971; as excepted compounds under Section 1308.32, and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances | 1405 |
|---|---|---|
| 2. | Benzphetamine (Federal Control June 15, 1973; State July 15, 1973) | 1228 |
| 3. | Chlorphentermine (Federal Control June 15, 1973; State July 15, 1973) | 1645 |
| 4. | Clortermine (Federal Control June 15, 1973; State July 15, 1973) | 1647 |
| 5. | Phendimetrazine (Federal Control June 15, 1973; State July 15, 1973) | 1615 |
| 6. | Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under Section 505 of the Federal Food, Drug, and Cosmetic Act (Federal Control Mar. 13, 2000; State April 12, 2000) | 2012 |
(c) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:
| 1. | Any compound, mixture, or preparation containing: | |
|---|---|---|
| (i) | Amobarbital | 2126 |
| (ii) | Secobarbital | 2316 |
| (iii) | Pentobarbital or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule. | 2271 |
| 2. | Any suppository dosage form containing: | |
| (i) | Amobarbital | 2126 |
| (ii) | Secobarbital | 2316 |
| (iii) | Pentobarbital or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository. | 2271 |
| 3. | Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof. | 2100 |
| (i) | All exceptions listed under Federal Control to barbituric acid derivative compounds that contain butalbital are fully regulated in Schedule III. (State Control Mar. 27, 2007) | |
| 4. | Chlorexadol | 2510 |
| 5. | Embutramide | 2020 |
| 6. | Any drug product containing gamma hydroxybutyric acid including its salts, isomers, and salts of isomers, for which an application is approved under Section 505 of the Federal Food, Drug, and Cosmetic Act (Federal Control Mar. 13, 2000; State Control April 12, 2000) | 2012 |
| 7. | Ketamine, its salts, isomers, and salts of isomers (Some other names for ketamine: (±)-2-(2-chlorophenyl)-2- (methylamino)-cyclohexanone]) (State Control April 24, 1999; Federal Aug. 12, 1999) | 7285 |
| 8. | Lysergic acid | 7300 |
| 9. | Lysergic acid amide | 7310 |
| 10. | Methyprylon | 2575 |
| 11. | Sulfondiethylmethane | 2600 |
| 12. | Sulfonethylmethane | 2605 |
| 13. | Sulfonmethane | 2610 |
| 14. | Tiletamine and zolazepam or any salt thereof (Some trade or other names for a tiletamine-zolazepam combination product: Telazol) (Some trade or other names for tiletamine: 2-(ethylamino)-2-(2-thinenyl)-cyclohexanone) (Some trade or other names for zolazepam: 4-(2-flurophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-3,4-e)(1,4)-diazepin-7(1H)-one, flupyrazapon (Federal Control Feb. 20, 1987; State Mar. 22, 1987) | 7295 |
| 15. | Perampanel, and its salts, isomers, and salts of isomers (Federal Control Feb. 20, 1987; State Feb. 2, 1987 | 2261 |
(d) Nalorphine 9400
(e) Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:
- Any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:
| (i) | Cough Syrups Containing Codeine were placed in Schedule III by the State Committee of Public Health on Mar. 20, 1974. | |
|---|---|---|
| (ii) | Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium. | 9803 |
| (iii) | Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts. | 9804 |
| (iv) | Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized therapeutic amounts | 9807 |
| (v) | Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts | 9808 |
| (vi) | Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts | 9809 |
| (vii) | Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, non-narcotic ingredients in recognized therapeutic amounts | 9810 |
- Any material, compound, mixture, or preparation containing any of the following narcotic drugs or their salts, as set forth below:
| (i) | Buprenorphine (Rescheduled Federally Oct. 7, 2002; State Nov. 6, 2002) | 9064 |
|---|---|---|
| (ii) | [Reserved] |
(f) Anabolic steroids. Unless specifically excepted or unless listed in another schedule, any substance meeting the definition of anabolic steroid as set forth in § 1300.01 of this chapter, including any material, compound, mixture, or preparation containing any quantity of the following substances, including its salts, esters, and ethers (4000):
| 1. | Anabolic Steroids (Federal Control Feb. 27, 1991; State Control May 1, 1986. Transferred from Schedule V effective Mar. 29, 1991) |
|---|---|
| 2. | Methasterone (2α, 17α-dimethyl-5α-androstan-17β-ol-3-one) (Federal Control July 30, 2012; State Control Aug. 29, 2012) |
| 3. | Prostanozol (17β-hydroxy-5α-androstano[3,2-c]pyrazole) (Federal Control July 30, 2012; State Control Aug. 29, 2012) |
| 4. | 5α-androstan-3,17-dione (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 5. | 5α-androstan-3,6,17-trione (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 6. | 1-androstenediol (3ß,17ß-dihydroxy-5α-androst-1-ene) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 7. | 1-androstenediol (3α,17ß-dihydroxy-5α-androst-1-ene) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 8. | 4-androstenediol (3ß,17ß-dihydroxy-androst-4-ene) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 9. | 5-androstenediol (3ß,17ß-dihydroxy-androst-5-ene) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 10. | 1-androstenedione (5α-androst-1-en-3,17-dione) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 11. | 4-androstenedione (androst-4-en-3,17-dione) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 12. | 5-androstenedione (androst-5-en-3,17-dione) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 13. | bolasterone (7α,17α-dimethyl-17β-hydroxyandrost-4-en-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 14. | boldenone (17β-hydroxyandrost-1,4-diene-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 15. | boldione (androsta-1,4-diene-3,17-dione) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 16. | 6-bromo-androsta-1,4-diene-3,17-dione (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 17. | 6-bromo-androstan-3,17-dione (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 18. | calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4-en-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 19. | 4-chloro-17α-methyl-androsta-1,4-diene-3,17β-diol (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 20. | 4-chloro-chloro-17α-methyl-androst-4-ene-3β,17β-diol (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 21. | 4-chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 22. | 4-chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-dione (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 23. | clostebol (4-chloro-17β-hydroxyandrost-4-en-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 24. | dehydrochloromethyltestosterone (4-chloro-17β-hydroxy-17α-methyl-androst-1,-4-dien-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 25. | desoxymethyltestosterone (17α-methyl-5α-androst-2-en-17β-ol) (a.k.a. "madol") (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 26. | 4-dihydrotestosterone (17β-hydroxy-androstan-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 27. | Δ1-dihydrotestosterone (a.k.a. "1-testosterone") (17β-hydroxy-5α-androst-1-en-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 28. | 3β,17β-dihydroxy-5α-androstane (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 29. | 3α,17β-dihydroxy-5α-androstane (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 30. | 2α,17α-dimethyl-17β-hydroxy-5β-androstan-3-one (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 31. | drostanolone (17β-hydroxy-2α-methyl-5α-androstan-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 32. | 2α,3α-epithio-17α-methyl-5α-androstan-17β-ol (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 33. | estra-4,9,11-triene-3,17-dione (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 34. | 13β-ethyl-17β-hydroxygon-4-en-3-one (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 35. | ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 36. | fluoxymesterone (9-fluoro-17α-methyl-11β,17β-dihydroxyandrost-4-en-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 37. | formebolone (2-formyl-17amethyl-11a,17b-dihydroxyandrost-1,4-dien-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 38. | furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]furazan) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 39. | [3,2-c]furazan-5a-androstan-17β-ol (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 40. | 18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 41. | 4-hydroxy-19-nortestosterone (4,17β-dihydroxy-estr-4-en-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 42. | 4-hydroxy-androst-4-ene-3,17-dione (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 43. | 17β-hydroxy-androstano[2,3-d]isoxazole (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 44. | 17β-hydroxy-androstano[3,2-c]isoxazole (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 45. | 3β-hydroxy-estra-4,9,11-trien-17-one (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 46. | 4-hydroxytestosterone (4,17β-dihydroxy-androst-4-en-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 47. | mestalnolone (17α-methyl-17β-hydroxy-5α-androstan-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 48. | mesterolone (1α-methyl-17β-hydroxy-5α-androstan-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 49. | methandienone (17α-methyl-17β-hydroxyandrost-1,4-dien-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 50. | methandriol (17α-methyl-3β,17β-dihydroxyandrost-5-ene) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 51. | methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-3-one or 2α,17α-dimethyl-17β-hydroxy-5α-androstan-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 52. | methenolone (1-methyl-17β-hydroxy-5α-androst-1-en-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 53. | 17α-methyl-androsta-1,4-diene-3,17β-diol (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 54. | 17α-methyl-5α-androstan-17β-ol (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 55. | 17α-methyl-androstan-3-hydroxyimine-17β-ol (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 56. | 6α-methyl-androst-4-ene-3,17-dione (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 57. | 17α-methyl-androst-2-ene-3,17β-diol (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 58. | 17α-methyl-3β,17β-dihydroxy-5α-androstane (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 59. | 17α-methyl-3α,17β-dihydroxy-5α-androstane (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 60. | 17α-methyl-3β,17β-dihydroxyandrost-4-ene (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 61. | 17α-methyl-4-hydroxynandrolone (17α-methyl-4-hydroxy-17β-hydroxyestr-4-en-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 62. | methyldienolone (17α-methyl-17β-hydroxyestra-4,9(10)-dien-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 63. | 17α-methyl-Δ1-dihydrotestosterone(17β-hydroxy-17α-methyl-5α-androst-1-en-3-one) (a.k.a. "17-α-methyl-1-testosterone") (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 64. | methyltestosterone (17α-methyl-17β-hydroxyandrost-4-en-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 65. | methyltrienolone (17α-methyl-17β-hydroxyestra-4,9,11-trien-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 66. | mibolerone (7α,17α-dimethyl-7β-hydroxyestr-4-en-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 67. | nandrolone (17β-hydroxyestr-4-en-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 68. | 19-nor-4-androstenediol (3β,17β-dihydroxyestr-4-ene) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 69. | 19-nor-4-androstenediol (3α,17β-dihydroxyestr-4-ene) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 70. | 19-nor-5-androstenediol (3β,17β-dihydroxyestr-5-ene) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 71. | 19-nor-5-androstenediol (3α,17β-dihydroxyestr-5-ene) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 72. | 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 73. | 19-nor-4-androstenedione (estr-4-en-3,17-dione) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 74. | 19-nor-5-androstenedione (estr-5-en-3,17-dione) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 75. | norbolethone (13β,17α-diethyl-17β-hydroxygon-4-en-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 76. | norclostebol (4-chloro-17β-hydroxyestr-4-en-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 77. | norethandrolone (17α-ethyl-17β-hydroxyestr-4-en-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 78. | normethandrolone (17α-methyl-17β-hydroxyestr-4-en-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 79. | oxandrolone (17α-methyl-17β-hydroxy-2-oxa-5α-androstan-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 80. | oxymesterone (17α-methyl-4,17β-dihydroxyandrost-4-en-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 81. | oxymetholone (17α-methyl-2-hydroxymethylene-17β-hydroxy-5α-androstan-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 82. | prostanozol (17β-hydroxy-5αandrostano[3,2-c]pyrazole or [3,2-c]pyrazole-5α-androstan-17β-ol) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 83. | [3,2-c]pyrazole-androst-4-en-17β-ol (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 84. | stanozolol (17α-methyl-17β-hydroxy-5α-androst-2-eno[3,2-c]-pyrazole) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 85. | stenbolone (17β-hydroxy-2-methyl-5α-androst-1-en-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 86. | testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 87. | testosterone (17β-hydroxyandrost-4-en-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 88. | tetrahydrogestrinone (13β-,17α-diethyl-17β-hydroxygon-4,9,11-trien-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 89. | trenbolone (17β-hydroxyestr-4,9,11-trien-3-one) (Federal Control Aug. 1, 2023; State Control Aug. 31, 2023) |
| 90. | Exempt anabolic steroid products. (Any anabolic steroid products --- exempted by the Federal Drug Enforcement Administration’s Controlled Substances List are included.) |
(g) Hallucinogenic substances.
| 1. | Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved drug product (Some other names for dronabinol: (6aR-trans)-6a,7,8, 10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-o1] or (-)-delta-9-(trans)-tetrahydrocannabinol) (Rescheduled Federally July 2, 1999; State Aug. 1, 1999) | 7369 |
|---|
(h) Any drug product exempted from control by the Federal Drug Enforcement Administration will also be exempted from the Alabama Controlled Substances List unless the State Committee of Public Health takes additional action.
Schedule IV
(a) Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.
(b) Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:
| 1. | Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit (Federal Control Sept. 27, 1978; State Oct. 27, 1978) | 9167 |
|---|---|---|
| 2. | Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane) (Federal Control Mar. 14, 1977; State April 13, 1977. Federal classification as narcotic drug July 24, 1980) | 9278 |
| 3. | Butorphanol (State Control Sept. 24, 1997) | |
| 4. | 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl]cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol) (Federal Control Aug. 18, 2014; State Sept. 18, 2014) | 9752 |
(c) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
| 1. | Alfaxalone (Federal Control Mar. 31, 2014; State April 30, 2014) | 2731 |
|---|---|---|
| 2. | Alprazolam (Federal Control Nov. 12, 1981; State Dec. 12, 1981) | 2882 |
| 3. | Barbital | 2145 |
| 4. | Brexanolone (Federal Control June 17, 2019; State Control July 17, 2019) | 2400 |
| 5. | Bromazepam (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2743 |
| 6. | Camazepam (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2749 |
| 7. | Carisoprodol (State Control Jan. 1, 1998; Federal Control Jan. 11, 2012) | 8192 |
| 8. | Chloral betaine | 2460 |
| 9. | Chloral hydrate | 2465 |
| 10. | Chlordiazepoxide (Federal and State Control July 2, 1975) | 2744 |
| 11. | Clobazam (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2751 |
| 12. | Clonazepam (Federal and State Control July 2, 1975) | 2737 |
| 13. | Clorazepate (Federal and State Control July 2, 1975) | 2768 |
| 14. | Clotiazepam (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2752 |
| 15. | Cloxazolam (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2753 |
| 16. | Daridorexant (Federal Control Oct. 31, 2022; State Nov. 30, 2022) | 2410 |
| 17. | Delorazepam (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2754 |
| 18. | Diazepam (Federal and State Control July 2, 1975) | 2765 |
| 19. | Dichloralphenazone (Federal Control Aug. 16, 2001; State Sept. 15, 2001) | 2467 |
| 20. | Estazolam (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2756 |
| 21. | Ethchlorvynol | 2540 |
| 22. | Ethinamate | 2545 |
| 23. | Ethyl loflazepate (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2758 |
| 24. | Fludiazepam (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2759 |
| 25. | Flunitrazepam (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2763 |
| 26. | Flurazepam (Federal and State Control July 2, 1975) | 2767 |
| 27. | Fospropofol (Federal Control Nov. 5, 2009; State Dec. 5, 2009) | 2138 |
| 28. | Halazepam (Federal Control Oct. 29, 1981; State Nov. 28, 1981) | 2762 |
| 29. | Haloxazolam (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2771 |
| 30. | Ketazolam (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2772 |
| 31. | Lemborexant (Federal Control Mar. 3, 2021; State Apr. 2, 2021) | 2245 |
| 32. | Loprazolam (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2773 |
| 33. | Lorazepam (Federal Control Oct. 3, 1977; State Nov. 2, 1977) | 2885 |
| 34. | Lormetazepam (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2774 |
| 35. | Mebutamate (Federal and State Control July 2, 1975) | 2800 |
| 36. | Medazepam (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2836 |
| 37. | Meprobamate | 2820 |
| 38. | Methohexital | 2264 |
| 39. | Methylphenobarbital (mephobarbital) | 2250 |
| 40. | Midazolam (Federal Control Mar. 25, 1986; State April 24, 1986) | 2884 |
| 41. | Nimetazepam (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2837 |
| 42. | Nitrazepam (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2834 |
| 43. | Nordiazepam (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2838 |
| 44. | Oxazepam (Federal and State Control July 2, 1975) | 2835 |
| 45. | Oxazolam (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2839 |
| 46. | Paraldehyde | 2585 |
| 47. | Petrichloral | 2591 |
| 48. | Phenobarbital | 2285 |
| 49 | Pinazepam (Federal Nov. 5, 1984; State Dec. 5, 1984) | 2883 |
| 50. | Prazepam (Federal Control Dec. 17, 1976; State Jan. 16, 1977) | 2764 |
| 51. | Quazepam (Federal Mar. 25, 1986; State April 24, 1986) | 2881 |
| 52. | Remimazolam (Federal July 2, 2021; State August 1, 2021) | 2846 |
| 53. | Suvorexant (Federal Control Sept. 29, 2014; State Oct. 29, 2014) | 2223 |
| 54. | Temazepam (Federal Control April 7, 1981; State May 7, 1981) | 2925 |
| 55. | Tetrazepam (Federal Control Nov. 5, 1984; State Dec. 5, 1984) | 2886 |
| 56. | Triazolam (Federal Control Dec. 28, 1982; State Jan. 27, 1983) | 2887 |
| 57. | Zaleplon (Federal Control Sept. 15, 1999; State Oct. 15, 1999) | 2781 |
| 58. | Zolpidem (Federal Control Feb. 5, 1993; State Mar. 7, 1993) | 2783 |
| 59. | Zopiclone (Federal Control April 4, 2005; State May 4, 2005) | 2784 |
| 60. | Zuranolone (Federal Control Sept. 13, 2024; State Oct. 13, 2024) | 2420 |
(d) [Reserved]
(e) Lorcaserin. Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:
| 1. | Lorcaserin (Federal Control Dec. 19, 2012; State Jan. 19, 2013) | 1625 |
|---|
(f) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, (whether optical, position, or geometric), and salts of such isomers is possible within the specific chemical designation:
| 1. | Cathine ([+]-norpseudoephedrine) (Federal Control June 16, 1988; State July 16, 1988) | 1230 |
|---|---|---|
| 2. | Diethylpropion (Federal Control June 15, 1973; State July 15, 1973) | 1608 |
| 3. | Fencamfamin (Federal Control June 16, 1988; State July 16, 1988) | 1760 |
| 4. | Fenproporex (Federal Control June 16, 1988; State July 16, 1988) | 1575 |
| 5. | Mazindol (Federal Control June 15, 1973; State July 15, 1973. Transferred Federally from Schedule III to IV Nov. 27, 1981; State Dec. 27, 1981) | 1605 |
| 6. | Mefenorex (Federal Control June 16, 1988; State July 16, 1988) | 1580 |
| 7. | Modafinil (Federal Control Jan. 27, 1999; State Feb. 26, 1999) | 1680 |
| 8. | Phentermine (Federal Control June 15, 1973; State July 15, 1973) | 1640 |
| 9. | Pemoline (including organometallic complexes and chelates thereof) (Federal Control Jan. 28, 1975; State Feb. 27, 1975) | 1530 |
| 10. | Pipradrol (Federal Control Dec. 1, 1980; State Dec. 31, 1980) | 1750 |
| 11. | Serdexmethylphenidate (Federal Control July 25, 2022; State Control Aug. 25, 2022) | 1729 |
| 12. | Sibutramine (Federal Control Feb. 11, 1998; State Mar. 13, 1998) | 1675 |
| 13. | SPA ([-]-1-dimethylamino-1,2-diphenyl-ethane) (Federal Control Dec. 1, 1980; State Dec. 31, 1980) | 1635 |
| 14. | Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, betaamino-, carbamate (ester)) (Federal Control June 17, 2019; State Control July 17, 2019; Corrected November 8, 2019) | 1650 |
(g) Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts:
| 1. | Pentazocine (Federal Control Feb. 9, 1979; State Mar. 11, 1979, Rescheduling effective Sept. 23, 1988; All Pentazocine products moved to Schedule IV effective Sept. 1, 1994) | 9709 |
|---|---|---|
| 2. | Butorphanol (including its optical isomers) | 9720 |
| 3. | Propofol (State Control Aug. 24, 2012) | |
| 4. | Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol- 2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers (Federal Control Dec. 14, 2015; State Jan. 14, 2016) | 9725 |
(h) Any drug product exempted from control by the Federal Drug Enforcement Administration will also be exempted from the Alabama Controlled Substances List unless the State Committee of Public Health takes additional action.
Schedule V
(a) Schedule V shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.
(b) Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs and their salts, as set forth below:
- [Reserved]
(c) Narcotic drugs containing non-narcotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below, which shall include one or more non-narcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by narcotic drugs alone:
| 1. | Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams |
|---|---|
| 2. | Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams |
| 3. | Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams |
| 4. | Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit |
| 5. | Not more than 100 milligrams of opium per 100 milliliters or per 100 grams |
| 6. | Not more than 0.5 milligrams of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit. (Federal Control Sept. 27, 1978; State Oct. 27, 1978) |
(d) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having stimulant effect on the central nervous system, including its salts, isomers and salts of isomers:
| 1. | Pyrovalerone (Federal Control May 4, 1988; State June 3, l988) | 1485 |
|---|---|---|
| 2. | [Reserved] |
(e) Depressants. Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts:
| 1. | Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-l-yl] butanamid) (also referred to as BRV; UCB-34714; Briviact) (including its salts) (Federal Control Mar. 9, 2017; State April 8, 2017) | 2710 |
|---|---|---|
| 2. | Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate; 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester) (Federal Control Aug. 20, 2020; State Sept. 19, 2020) | 2720 |
| 3. | Ezogabine [N-[2-amonio-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester] (Federal Control Dec. 15, 2011; State Jan. 20, 2012) | 2779 |
| 4. | Ganaxolone (3α-hydroxy-3β-methyl-5α-pregnan-20-one) (Federal Control Dec. 9, 2022; State Jan. 8, 2023) | 2401 |
| 5. | Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide] (Federal Control June 22, 2009; State July 22, 2009) | 2746 |
| 6. | Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide(including its salts)] (Federal Control May 24, 2021; State June 23, 2021) | 2790 |
| 7. | Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid] (Federal Control July 28, 2005; State Aug. 28, 2005) | 2782 |
| 8. | Gabapentin (State Control Nov. 18, 2019) |
(f) Any drug product exempted from control by the Federal Drug Enforcement Administration will also be exempted from the Alabama Controlled Substances List unless the State Committee of Public Health takes additional action.
History
- Author: Dr. Jim McVay
- Authority: Code of Ala. 1975, §§20-2-20, et seq.
- Filed September 1, 1982. Publication of Controlled Substances List: Filed September 23, 1983. (Published in Vol. I, No. 12, AAM, September 30, 1983.) Amended: Filed June 22, 1984; July 24, 1984; September 27, 1984. Publication of Controlled Substances List: Filed September 27, 1984. (Published in Vol. III, No. 1, AAM, October 31, 1984.) Amended: Filed November 7, 1984; April 9, 1985; May 20, 1985; July 24, 1985; August 23, 1985. Publication of Controlled Substances List: Filed September 23, 1985. (Published in Vol. III, No. 12, AAM, September 30, 1985.) Amended: Filed December 30, 1985; February 20, 1986; April 22, 1986; May 23, 1986. Ed. Note: Continued temporary scheduling of 3-methylfentanyl at Schedule I, item (g)(1). Amended: Filed June 23, 1986; July 24, 1986. Ed. Note: Continued temporary scheduling of 3, 4-methylenedioxy -methamphetamine at Schedule I, item (g)(2). Amended: Filed September 23, 1986. Ed. Note: Continued temporary scheduling of 1-methyl-4phenyl-4-propionoxy piperidine (MPPP) and 1-(2-phenethyl)-phenyl-4-acetoxy- piperidine (PEPAP) at Schedule I, item (g)(3)(4). Publication of Controlled Substances List: Filed September 23, 1986. (Published in Vol. IV, No. 12, AAM, September 30, 1986.) Amended: Filed October 24, 1986; November 19, 1986; December 19, 1986. Ed. Note: Continued temporary scheduling of acetyl-alpha-methylfentanyl, alpha- methylthiofentanyl, beta-hydroxyfentanyl, beta-hydoxy-3- methylfentanyl, 3-methyl-thio-fentanyl and thiofentanyl at Schedule I, item (g)(3)(4)(6)(7)(8)(10). Amended: Filed February 20, 1987; April 23, 1987. Ed. Note: Continued temporary scheduling of parafluorofentanyl at Schedule I, item (g)(9). Amended: Filed April 23, 1987; June 23, 1987. Publication of Controlled Substances List: Filed September 23, 1987. (Published In Vol. V, No. 12, AAM, September 30, 1987.) Amended: Filed November 19, 1987; February 22, 1988; March 24, 1988; May 24, 1988; June 20, 1988; August 19, 1988; September 23, 1988. Publication of Controlled Substances List: Filed September 23, 1988. (Published in Vol. VI, No. 12, AAM, September 30, 1988.) Amended: Filed November 21, 1988. (Ed. Note: Continued scheduling of 3,4-methylenedioxy-N- ethylamphetamine, N-hydroxy-3, 4-methylenedioxyamphetamine and 4-methylaminorex in Schedule I, item (g), 3., 4., and 5.). Amended: Filed May 19, 1989; August 21, 1989. Publication of Controlled Substances List: Filed September 20, 1989. (Published in Vol. VII, No. 12, AAM, September 29, 1989.) Amended: Filed March 21, 1990. Publication of Controlled Substances List: Filed September 19, 1990. Published in Vol. VIII, No. 12, September 28, 1990.) Amended: Filed March 21, 1991; April 19, 1991. Publication of Controlled Substances List: Filed September 19, 1991. (Published in Vol. IX, No. 12, AAM, September 30, 1991.) Amended: Filed December 18, 1991; May 20, 1992; August 21, 1992. Amended: Filed September 21, 1992; Publication of Controlled Substances List: Filed September 21, 1992; (Published in Vol. XI, No. 1, AAM, October 30, 1992.) effective December 16, 1992. Amended: Filed May 20, 1993; effective June 24, 1993. Amended: Filed July 21, 1993; effective August 25, 1993. Publication of Controlled Substances List: Filed September 21, 1993. (Published in Vol. XI, No. 12, AAM, September 30, 1993). Amended: Filed October 20, 1993. Amended: Filed July 21, 1994; effective August 25, 1994. Publication of Controlled Substances List: Filed September 21, 1994. (Published in Vol. XII, No. 12, AAM, September 30, 1994). Publication of Controlled Substances List: Filed September 22, 1995. (Published in Vol. XIII, No. 12, AAM, September 29, 1995). Publication of Controlled Substances List: Filed September 20, 1996. (Published in Vol. XIV, No. 12, AAM, September 30, 1996). Effective December 20, 1996. Amended: Filed August 20, 1997; effective September 24, 1997. Publication of Controlled Substances List: Filed September 19, 1997. (Published in Vol. XV, No. 12, AAM, September 30, 1997). Amended: Filed November 20, 1997; effective December 25, 1997. Amended: Filed February 20, 1998; effective March 13, 1998. Amended: Filed August 20, 1998; effective September 24, 1998. Publication of Controlled Substances List: Filed September 18, 1998; (Published in Vol. XVI, No. 12, AAM, September 30, 1998.) effective October 1, 1998. Amended: Filed September 18, 1998; effective October 23, 1998. Amended: Filed February 19, 1999; effective February 26, 1999. Amended: Filed March 22, 1999; effective April 26, 1999. Amended: Filed August 20, 1999; effective August 1, 1999. Publication of Controlled Substances List: Filed September 17, 1999; (Published in Vol. XVII, No. 12, AAM, September 30, 1999.) Amended: Filed October 20, 1999; effective October 15, 1999. Amended: Filed March 17, 2000; effective April 12, 2000. Amended: Filed March 17, 2000; effective April 21, 2000. Amended: Filed November 20, 2000; effective December 25, 2000. Amended: Filed January 3, 2001; effective December 17, 2000. Publication of Controlled Substances List: Filed January 18, 2001; (Published in Vol. XIX, No. 4, AAM, February 1, 2001.) Amended: Filed September 20, 2001; effective September 15, 2001. Amended: Filed September 20, 2001; effective September 19, 2001. Publication of Controlled Substances List: Filed September 20, 2001; (Published in Vol. XIX, No. 12, AAM, September 28, 2001). Publication of Controlled Substances List: Filed September 18, 2002; (Published in Vol. XX, No. 12, AAM, September 30, 2002). Amended: Filed October 15, 2002; effective October 20, 2002. Amended: Filed October 15, 2002; effective November 6, 2002. Amended: Filed April 17, 2003; effective May 4, 2003. Publication of Controlled Substances List: Filed September 18, 2003; (Published in Vol. XXI, No. 12, AAM, September 30, 2003). Amended: Filed April 21, 2004; effective April 17, 2004. Publication of Controlled Substances List: Filed September 20, 2004; (Published in Vol. XXII, No. 12, AAM, September 30, 2004). Amended: Filed October 21, 2004; effective October 29, 2004. Amended: Filed April 20, 2005; effective May 4, 2005. Amended: Filed August 22, 2005; effective August 28, 2005. Publication of Controlled Substances List: Filed September 21, 2005; (Published in Vol. XXIII, No. 12, AAM, September 30, 2005). Publication of Controlled Substances List: Filed October 20, 2005; (Published in Vol. XXIV, No. 1, AAM, October 31, 2005). Publication of Controlled Substances List: Filed September 20, 2006; (Published in Vol. XXIV, No. 12, AAM, September 29, 2006). Amended: Filed October 19, 2006; effective October 28, 2006. Amended: Filed February 21, 2007; effective March 28, 2007. Amended: Filed June 20, 2007; effective July 4, 2007. Amended: Filed October 19, 2007; effective November 23, 2007. Publication of Controlled Substances List: Filed November 13, 2007; (Published in Vol. XXVI, No. 2, AAM, November 30, 2007). Publication of Controlled Substances List: Filed September 22, 2008; (Published in Vol. XXVI, No. 12, AAM, September 30, 2008). Amended: Filed June 26, 2009; effective July 22, 2009. Publication of Controlled Substances List: Filed September 17, 2009; (Published in Vol. XXVII, No. 12, AAM, September 30, 2009). Amended: Filed October 21, 2009; effective November 5, 2009. Publication of Controlled Substances List: Filed January 19, 2011; (Published in Vol. XXIX, No. 4, AAM, January 31, 2011). Amended: Filed March 17, 2011; effective March 31, 2011. Amended: Filed May 26, 2011; effective June 30, 2011. Amended: Filed December 21, 2011; effective January 1, 2012. Amended: Filed December 21, 2011; effective January 25, 2012. Publication of Controlled Substances List: Filed January 19, 2012; (Published in Vol. XXX, No. 4, AAM, January 31, 2012). Amended: Filed January 20, 2012; effective January 20, 2012. Amended: Filed July 23, 2012; effective August 27, 2012. Amended: Filed October 18, 2012; effective November 22, 2012. Amended: Filed January 2, 2013; effective January 20, 2013; (Published in Vol. XXXI, No. 4, AAM, January 31, 2013). Publication of Controlled Substances List: Filed January 17, 2013; (Published in Vol. XXXI, No. 4, AAM, January 31, 2013). Amended: Filed February 20, 2013; effective February 3, 2013; (Published in Vol. XXXI, No. 5, AAM, February 28, 2013). Amended: Filed April 12, 2013; effective May 17, 2013. Amended: Filed June 20, 2013; effective June 16, 2013; (Published in Vol. XXXI, No. 9, AAM, June 28, 2013). Amended: Filed January 2, 2014; effective February 2, 2014; (Published in Vol. XXXII, No. 4, AAM, January 31, 2014). Publication of Controlled Substances List: Filed February 20, 2014; (Published in Vol. XXXII, No. 5, AAM, February 28, 2014). Amended: Filed February 28, 2014; effective March 10, 2014; (Published in Vol. XXXII, No. 6, AAM, March 31, 2014). Amended: Filed March 20, 2014; effective April 7, 2014; (Published in Vol. XXXII, No. 6, AAM, March 31, 2014). Amended: Filed March 20, 2014; effective April 30, 2014; (Published in Vol. XXXII, No. 6, AAM, March 31, 2014). Amended: Filed June 20, 2014; effective July 25, 2014. Amended: Filed July 24, 2014; effective September 18, 2014; (Published in Vol. XXXII, No. 11, AAM, August 29, 2014). Amended: Filed September 19, 2014; effective October 29, 2014; (Published in Vol. XXXII, No. 12, AAM, September 30, 2014). Amended: Filed September 19, 2014; effective November 6, 2014; (Published in Vol. XXXII, No. 12, AAM, September 30, 2014). Publication of Controlled Substances List: Filed January 23, 2015; (Published in Vol. XXXIII, No. 4, AAM, January 30, 2015). Amended: Filed February 19, 2014; effective March 1, 2015; (Published in Vol. XXXIII, No. 5, AAM, February 27, 2015). Amended: Filed February 19, 2015; effective February 23, 2015; (Published in Vol. XXXIII, No. 5, AAM, February 27, 2015). Amended: Filed September 17, 2015; effective October 11, 2015; (Published in Vol. XXXIII, No. 12, AAM, September 30, 2015). Amended: Filed November 19, 2015; effective December 13, 2015; (Published in Vol. XXXIV, No. 2, AAM, November 30, 2015). Amended: Filed December 18, 2015; effective February 1, 2016. Publication of Controlled Substances List: Filed January 20, 2016; (Published in Vol. XXXIV, No. 4, AAM, January 29, 2016). Amended: Filed May 19, 2016; effective June 15, 2016; (Published in Vol. XXXIV, No. 8, AAM, May 31, 2016). Amended: Filed July 20, 2016; effective June 10, 2016; (Published in Vol. XXXIV, No. 10, AAM, July 31, 2016). Amended: Filed September 21, 2016; effective October 6, 2016; (Published in Vol. XXXIV, No. 12, AAM, September 30, 2016). Amended: Filed October 20, 2016; effective November 26, 2016; (Published in Vol. XXXV, No. 1, AAM, October 31, 2016). Amended: Filed November 17, 2016; effective December 14, 2016; (Published in Vol. XXXV, No. 2, AAM, November 30, 2016). Amended: Filed December 15, 2016; effective December 28, 2016; (Published in Vol. XXXV, No. 3, AAM, December 30, 2016). Publication of Controlled Substances List: Filed January 18, 2017; (Published in Vol. XXXV, No. 4, AAM, January 31, 2017). Amended: Filed March 16, 2017; effective April 8, 2017; (Published in Vol. XXXV, No. 6, AAM, March 31, 2017). Amended: Filed July 21, 2017; effective August 13, 2017; (Published in Vol. XXXV, No. 10, AAM, July 31, 2017). Amended: Filed October 19, 2017; effective October 28, 2017; (Published in Vol. XXXVI, No. 1, AAM, October 31, 2017). Amended: Filed October 19, 2017; effective November 15, 2017; (Published in Vol. XXXVI, No. 1, AAM, October 31, 2017). Amended: Filed January 19, 2018; effective December 22, 2017; (Published in Vol. XXXVI, No. 4, AAM, January 31, 2018). Publication of Controlled Substances List: Filed February 21, 2018; (Published in Vol. XXXVI, No. 5, AAM, February 28, 2018). Amended: Filed May 18, 2018; effective May 20, 2018; (Published in Vol. XXXVI, No. 8, AAM, May 31, 2018). Amended: Filed July 19, 2018; effective September 2, 2018. Amended: Filed October 18, 2018; effective October 28, 2018; (Published in Vol. XXXVII, No. 1, AAM, October 31, 2018). Amended: Filed December 13, 2018; effective December 29, 2018; (Published in Vol. XXXVII, No. 3, AAM, December 28, 2018). Publication of Controlled Substances List: Filed January 10, 2019; (Published in Vol. XXXVII, No. 4, AAM, January 31, 2019). Amended: Filed February 20, 2019; effective February 28, 2019. (Published in Vol. XXXVII, No. 5, AAM, February 28, 2019). Amended: Filed February 20, 2019; effective March 9, 2019. (Published in Vol. XXXVII, No. 5, AAM, February 28, 2019). Amended: Filed May 17, 2019; effective June 7, 2019. (Published in Vol. XXXVII, No. 8, AAM, May 31, 2019). Amended: Filed May 17, 2019; effective July 1, 2019. (Published in Vol. XXXVII, No. 8, AAM, May 31, 2019). Amended: Filed July 17, 2019; effective July 17, 2019 and July 18, 2019. (Published in Vol. XXXVII, No. 10, AAM, July 31, 2019). Amended: Filed August 21, 2019; effective September 15, 2019. (Published in Vol. XXXVII, No. 11, AAM, August 30, 2019). Amended: Filed November 20, 2019; effective November 24, 2019. (Published in Vol. XXXVIII, No. 2, AAM, November 29, 2019). Publication of Controlled Substances List: Filed January 21, 2020; (Published in Vol. XXXVIII, No. 4, AAM, January 31, 2020). Amended: Filed February 19, 2020; effective February 23, 2020. (Published in Vol. XXXVIII, No. 5, AAM, February 28, 2020). Amended: Filed April 17, 2020; effective April 29, 2020. (Published in Vol. XXXVIII, No. 7, AAM, April 30, 2020). Amended: Filed May 20, 2020; effective June 17, 2020. (Published in Vol. XXXVIII, No. 8, AAM, May 29, 2020). Amended: Filed September 16, 2020; effective September 19, 2020. (Published in Vol. XXXVIII, No. 12, AAM, September 30, 2020). Amended: Filed October 20, 2020; effective November 1, 2020. (Published in Vol. XXXIX, No. 1, AAM, October 30, 2020). Amended: Filed December 17, 2020; effective December 25, 2020. (Published in Vol. XXXIX, No. 3, AAM, December 31, 2020). Publication of Controlled Substances List: Filed January 20, 2021; (Published in Vol. XXXIX, No. 4, AAM, January 29, 2021). Amended: Published January 29, 2021; effective March 15, 2021. Amended: Filed March 22, 2021; effective April 2, 2021. (Published in Vol. XXXIX, No. 6, AAM, March 31, 2021). Amended: Filed May 19, 2021; effective May 19, 2021. (Published in Vol. XXXIX, No. 8, AAM, May 28, 2021). Amended: Filed May 19, 2021; effective May 27, 2021. (Published in Vol. XXXIX, No. 8, AAM, May 28, 2021). Amended: Filed May 19, 2021; effective June 3, 2021. (Published in Vol. XXXIX, No. 8, AAM, May 28, 2021). Amended: Filed June 17, 2021; effective June 23, 2021. (Published in Vol. XXXIX, No. 9, AAM, June 30, 2021). Amended: Filed June 17, 2021; effective July 10, 2021. (Published in Vol. XXXIX, No. 9, AAM, June 30, 2021). Amended: Filed June 17, 2021; effective August 1, 2021. (Published in Vol. XXXIX, No. 9, AAM, June 30, 2021). Amended: Filed June 17, 2021; effective August 11, 2021. (Published in Vol. XXXIX, No. 9, AAM, June 30, 2021). Amended: Filed July 17, 2021; effective July 14, 2021. (Published in Vol. XXXIX, No. 10, AAM, July 30, 2021). Amended: Filed July 17, 2021; effective July 22, 2021. (Published in Vol. XXXIX, No. 10, AAM, July 30, 2021). Amended: Published July 30, 2021; effective September 13, 2021. Amended: Published September 30, 2021; effective November 14, 2021. Publication of Controlled Substances List: Filed January 20, 2022; (Published in Vol. XL, No. 4, AAM, January 31, 2022). Amended: Published May 31, 2022; effective July 15, 2022. Amended: Published June 30, 2022; effective July 1, 2022, and July 6, 2022. (Published in Vol. XL, No. 9, AAM, June 30, 2022.) Amended: Published July 29, 2022; effective August 24, 2022. (Published in Vol. XL, No. 10, AAM, July 29, 2022.) Amended: Published October 31, 2022; effective November 30, 2022. (Published in Vol. XLI, No. 1, AAM, October 31, 2022.) Amended: Published November 30, 2022; effective January 5, 2022. (Published in Vol. XLI, No. 2, AAM, November 30, 2022.) Amended: Published November 30, 2022; effective May 7, 2022. (Published in Vol. XLI, No. 2, AAM, November 30, 2022.) Amended: Published December 30, 2022; effective January 8, 2023; January 18, 2023; January 20, 2023; and January 21, 2023. (Published in Vol. XLI, No. 3, AAM, December 30, 2022.) Amended: Published December 30, 2022; effective February 13, 2023. Publication of Controlled Substances List: Published January 31, 2023; (Published in Vol. XLI, No. 4, AAM, January 31, 2023). Amended: Published January 31, 2023; effective January 19, 2023. Amended: Published May 31, 2023; approved May 18, 2023. (Published in Vol. XLI, No. 8, AAM, May 31, 2023.) Amended: Published July 31, 2023; effective September 14, 2023. Amended (Schedule I(b)93 and Schedule III(f)1-89): Published September 29, 2023; approved September 21, 2023. (Published in Vol. XLI, No. 12, AAM, September 29, 2023.) Amended: Published February 29, 2024; effective January 6, 2024. Amended: Published February 29, 2024; effective January 12, 2024. Amended: Published April 30, 2024; effective May 15, 2024. Amended: Published May 31, 2024; approved May 16, 2024 (Published in Vol. XLII, No. 8, May 31, 2024). Amended: Published May 31, 2024; effective July 15, 2024. Amended: Published September 30, 2024; effective October 13, 2024. Amended: Published November 27, 2024; effective November 21, 2024. Amended: Published December 31, 2024; effective November 24, 2024. Amended: Published April 30, 2025; effective June 14, 2025. Amended: Published September 30, 2025; effective October 7, 2025. Amended: Published November 26, 2025; effective October 18, 2025. Amended: Published December 31, 2025; effective February 14, 2026. Amended: Published February 27, 2026; effective February 19, 2026. Amended: Published March 31, 2026; effective March 19, 2026. Amended: Published April 30, 2026; effective April 9, 2026. Amended: Published June 30, 2026; effective May 22, 2026. Amended: Published June 30, 2026; effective June 18, 2026.
Poursuivez vos recherches dans ChatGPT ou Claude
Connectez Omnilex pour rechercher dans le corpus juridique depuis votre assistant IA.